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Executive Summary 
 
Promoting and protecting the health of Iowans is the mission of the Iowa Department of Public Health 
(IDPH). Surveillance of notifiable health conditions is essential in establishing what, how, and when 
events impact the public’s health. Once this information is gathered, public health and health care 
providers around the state are able to use this data to take steps to prevent illnesses from occurring.  
Multiple divisions and bureaus are dedicated to accomplishing the goals of surveillance. In 2014, there 
were more than 86,000 laboratory results of infectious diseases and conditions submitted to IDPH 
disease surveillance programs. IDPH also investigates non-infectious conditions related to lead, 
occupational, and environmental hazards like carbon monoxide. In 2014, approximately 71,000 
children’s and more than 7,000 adults’ blood tests results were reported to IDPH. 
 
Among vaccine-preventable diseases, pertussis cases decreased significantly in 2014, down over 70 
percent from the previous three-year average. Reported mumps cases increased, however. No measles 
cases were reported. Two cases of meningococcal invasive disease were reported, with one case caused 
by serogroup B, which is not covered by vaccines in the United States. The number of Hepatitis A cases 
decreased compared to 2013, but remained slightly higher than the previous three-year average. 
 
Several enteric diseases decreased to varying degrees compared to the previous three-year average, 
including campylobacter, cryptosporidiosis, giardia, and salmonellosis. E. coli and listeriosis both 
increased versus their three-year averages. Shigellosis decreased from 2013, but remained higher than 
the three-year average due to the exceptionally high number of cases reported in 2013. There were no 
cyclosporiasis cases reported in 2014, one year following a multi-state outbreak that infected 136 
Iowans. A total of 71 outbreaks were investigated, affecting nearly 1,500 Iowans, the largest of which 
was a norovirus outbreak that sickened 148 employees in a workplace. Among these outbreaks, 28 were 
influenza, most of which occurred in long-term care settings. The most common implicated pathogen 
was norovirus, and outbreaks occurred most frequently in restaurants, long-term care/assisted living 
facilities, schools/child care facilities, and homes. 
 
A range of vector-borne diseases affect Iowans each year. Some, such as Dengue fever, chikungunya, 
and malaria are only reported among those who have traveled. Among tick-borne diseases endemic to 
Iowa, Rocky Mountain spotted fever and ehrlichiosis/anaplasmosis increased slightly from 2013. Lyme 
disease decreased from 2013, though remained above the previous three-year average. West Nile virus, 
spread via mosquitos, decreased nearly 50 percent from the previous three-year average. 
 
Over the last decade in Iowa, chlamydia cases have increased while gonorrhea cases have remained 
relatively stable. This trend continued in 2014. Syphilis cases continued to increase, as they have each of 
the last three years, with over three times as many syphilis cases reported in 2014 than 2011. 
 
New diagnoses of HIV among Iowans numbered 99 in 2014, a 19 percent drop from the 122 diagnoses 
reported in 2013, and the fewest since 88 diagnoses were recorded in 2003. Continued surveillance will 
be necessary to determine if this is a temporary decrease or the start of a sustained downward trend.  
 
In addition to an overall decrease in new HIV diagnoses, the proportion of diagnoses among females 
declined from a high of 28 percent in 2013 to the long-term average of 20 percent in 2014. From 2005 
through 2014, there have been about four males diagnosed for every one female diagnosed. Although 
racial and ethnic minorities continue to be over-represented in HIV diagnoses, the disparity dropped 
markedly in 2014. Blacks/African-Americans represent 3 percent of Iowa’s population, but accounted for 
12 percent of HIV diagnoses in 2014. This percentage dropped from 21 percent in 2013. Such disparities 
aside, white non-Hispanic Iowans accounted for over 65 percent of new HIV diagnoses and persons 
Divisions of Acute Disease Prevention and Emergency Response, Environmental Health, and Behavioral Health 
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living with HIV disease. For the third year in a row, the proportion of “late testers” (those people who 
were diagnosed with AIDS within a year of their HIV diagnoses) increased. Nearly 50 percent of people 
diagnosed in 2013 had a late diagnosis. Because this measure requires a year to complete, the data for 
2014 is incomplete; however, early projections suggest late diagnoses will be less than 40 percent. 
 
The number of HIV-infected persons residing in Iowa at the end of 2014 was 2,369, a prevalence of 77 
per 100,000 people. As of December 31, 2014, 96 of Iowa’s 99 counties had at least one person living 
with HIV disease. HIV care continuum analysis found that of 2,295 persons diagnosed with HIV disease 
on or before December 31, 2013, and living in Iowa as of December 31, 2014, 1,655 (72 percent) had 
been retained in HIV care. Of the 1,655 retained in care, 1,552 (94 percent) had an HIV viral load less 
than 200 copies per milliliter of blood (viral suppression). Of the 2,295 persons (both in and out of care), 
1,552 (68 percent) were virally-suppressed. Studies have shown viral suppression optimizes individual 
health outcomes and may reduce the likelihood of transmitting HIV by 96 percent.  
 
Crucial partners contributing to the surveillance and reduction of these diseases include the State 
Hygienic Laboratory (SHL) at the University of Iowa, clinical laboratories, hospitals, city and county public 
health agencies, long-term health care facilities, schools, as well as health care providers, infection 
preventionists, and other health professionals. The Iowa Department of Public Health would like to take 
this opportunity to thank all of its partners for their continued support of disease surveillance in Iowa. 
 
Table 1. Summary of select reportable diseases and percent change in number of cases reported 
compared to three-year average - Iowa, 2011-2014ǂ 
 
2011 2012 2013 
3-yr average 
2011-2013 
2014 
Percent 
change† 
Campylobacteriosis 747 534 610 630 571 -9.37% 
Chlamydia 10928 11139 11006 11024 11807 7.10% 
Cryptosporidiosis 364 328 1505 732 264 -63.93% 
E. coli and other shiga-toxin producing  189 181 171 180 224 24.44% 
Giardiasis 271 251 275 266 205 -22.93% 
Gonorrhea 1966 1982 1473 1807 1641 -9.19% 
Hepatitis A 8 7 17 11 12 9.09% 
Hepatitis B, acute 15 12 11 13 9 -30.77% 
HIV (new diagnoses) 119 117 122 119 99 -16.81% 
Lead poisoning (child) * * 321 *    521 * 
Lead poisoning (adult) 832 818 856 835 759 -9.10% 
Legionellosis 11 13 11 12 33 175.00% 
Listeriosis 5 3 2 3 7 133.33% 
Lyme disease 100 165 247 171 194 13.45% 
Meningococcal invasive disease 14 2 1 6 2 -66.67% 
Mumps 8 6 3 6 10 66.67% 
Pertussis (whooping cough) 232 1736 308 759 222 -70.75% 
Salmonellosis 448 622 575 548 527 -3.83% 
Shigellosis 18 91 342 150 208 38.67% 
Syphilis 70 138 226 145 239 64.83% 
West Nile virus 9 31 44 28 15 -46.4% 
ǂ Table includes confirmed and probable cases 
†Percent change calculated by subtracting the 3-year average from the total cases for 2014 and dividing by the absolute value of the 3-  
  year average 
* Due to current changes in determining cases of lead poisoned children, case counts prior to 2013 are being revised and were not    
   available at the time this report was published. 
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Introduction 
The purpose of this report is to provide a snapshot of the types and trends of notifiable and other 
diseases that occur in Iowa. When possible, details specific to the disease are provided, including 
information on which serotypes, strains, or groups were prevalent, and which caused outbreaks. 
Comparisons to national rates are also provided whenever possible. Aggregated county-level data are 
provided in a table at the end of the report. The report is intended for use by the public, media, public 
health, and health care.  
 
The report is divided into the following sections: respiratory and vaccine-preventable diseases; sexually-
transmitted diseases; human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome 
(AIDS); hepatitis C; enteric diseases; zoonotic diseases; rare and unusual diseases; and environmental 
health conditions.  
 
The Iowa Department of Public Health (IDPH) has five divisions and of those, two contributed disease 
data to this report, including Behavioral Health (BH) and Acute Disease Prevention and Emergency 
Response and Environmental Health (ADPER & EH). The Division of Behavioral Health includes the 
Bureau of HIV, Sexually Transmitted Disease (STD), and Hepatitis which identifies, monitors, and 
supports persons with HIV/AIDS, STDs, and viral hepatitis. Disease reporting and tracking are a large 
component of the work accomplished by this bureau, as well as locating, counseling, and testing 
partners of persons with sexually transmitted diseases. 
 
The Division of Acute Disease Prevention and Emergency Response and Environmental Health (ADPER & 
EH) has six bureaus and of those, three bureaus contributed data to this report. Two bureaus are 
responsible for infectious disease investigation: the Center for Acute Disease Epidemiology (CADE) and 
the Bureau of Immunization and Tuberculosis (BIT). CADE conducts surveillance for common and 
emerging infectious diseases, agents of bioterrorism, disease outbreaks, and occurrence of rare and 
unusual acute diseases. BIT conducts surveillance for tuberculosis (TB) and perinatal hepatitis B, as well 
as coordinates the immunization program for the state. Specific disease conditions are reportable to the 
department per Iowa Administrative Code 641, Chapter 1. The urgency tied to reporting varies by 
disease1.  
 
The third ADPER & EH reporting bureau is the Bureau of Environmental Health Services (EHS), which is 
responsible for environmental health conditions investigation. Certain health conditions of 
environmental origin are required to be reported to IDPH per Iowa Administrative Code 641, Chapter 1. 
This report includes disease/outbreak surveillance, carbon monoxide poisoning, methemoglobinemia, 
child and adult blood lead levels, reports of other heavy metal poisonings, and fatal work-related 
traumatic injuries.  
 
Public health emergency response planning plays a major role in preparing IDPH to respond to events of 
public health significance. In the past several years, the department used the incident management 
system in response to several events, including severe weather in 2008 and the 2009 H1N1 pandemic. 
Preparedness planning at both the state and local levels has greatly improved the ability of public health 
to respond to large-scale disease outbreaks as well as natural disasters.  
 
This report provides an overview of disease investigations and represents only a fraction of work 
accomplished by IDPH staff each year. The time invested in each disease report varies greatly by disease 
and nature of the report. Some reports require a quick database query and update of an electronic file. 
Others require hours of staff time in contact tracing, mentoring and assisting other health investigators, 
and communication, education, and implementation of interventions. 
Divisions of Acute Disease Prevention and Emergency Response, Environmental Health, and Behavioral Health 
9 
 
Support for the initiatives of the ADPER & EH division comes from a variety of federal and state 
allocations and grants. The TB, STD, and HIV/AIDS surveillance programs are funded under separate 
cooperative agreements with the Centers for Disease Control and Prevention (CDC) and the National 
Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention. 
 
Methods 
Disease reports are submitted to IDPH via phone, fax, mail, or a secure electronic reporting system. 
Reporters include health care providers, hospitals, local public health agencies, laboratories, and the 
public. Reports of diseases or exposures occurring outside of Iowa can be reported by other states or 
CDC to IDPH via the Epi-X system. CADE tracks reports of disease in Iowa residents; however, acquisition 
or exposure to some illnesses may have occurred in Iowa, another state, or outside of the United States. 
 
Reports received by CADE are tracked in the secure web-based Iowa Disease Surveillance System (IDSS). 
De-identified data is electronically exchanged between IDSS and CDC.  
 
The Iowa Department of Public Health is in the midst of implementing statewide electronic laboratory 
reporting (ELR). ELR from the State Hygienic Laboratory (SHL) has been in place since March 2010. The 
national reference lab ARUP began sending ELR in July 2014. Since that time, 19 additional ELR 
connections have been established, all of which represent 68 different laboratory or hospital locations. 
Ongoing implementation plans include establishing 29 more ELR connections representing 57 different 
laboratories or hospitals. In addition, IDPH efforts are underway to implement ELR with other state 
public health jurisdictions for more efficient laboratory reporting. 
 
Cases of acute infectious disease are typically referred to local public health agencies for patient 
investigations and interviews. Agencies primarily use IDSS to report information back to IDPH. Local 
public health agencies are also critical in conducting outbreak investigations. These agencies work to 
identify, investigate, and contain outbreaks at the city and county level.  
 
A few diseases require a unique reporting system used by IDPH for transmitting de-identified data to 
program-specific staff at CDC. These diseases include influenza and West Nile virus. The National 
Outbreak Reporting System (NORS) is a CDC-sponsored system used by IDPH to report outbreaks.  
 
Rates were calculated using the 2010 census population for the State of Iowa or the appropriate 
estimated census year. The enteric disease five-year averages were calculated by taking the average of 
the previous five years’ case counts for each disease. This is in contrast to previous methods utilized in 
this report, which included adding the five-year average to two times the standard deviation (5-year 
average + 2(SD)). All case counts include cases that were and were not considered to be part of an 
outbreak investigation. This also differs from previous methods utilized in this report. Calculations were 
performed with SAS® 9.4, and Microsoft® Excel. Maps were generated using ARC GIS ® 10.0.  
 
CADE uses the most recent Council of State and Territorial Epidemiologists (CSTE)/CDC case definitions 
found at wwwn.cdc.gov/nndss/conditions/notifiable/2015/. CSTE/CDC definitions are used to classify 
each case as confirmed, probable, suspect, not a case, or awaiting more information. Only confirmed 
and probable cases meeting the CSTE/CDC definitions are included in this report.  
 
Disease case counts and Iowa-specific case demographics were retrieved from IDSS, which is maintained 
within CADE. The specific file used for this report was created in April 2015. Case reports and additional 
information received after this date that may have altered the disease counts were not included in this 
report. In addition, the data file was generated using MMWR (Morbidity Mortality Weekly Report) year 
Iowa Department of Public Health 
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2014. Therefore, case counts in this report may vary slightly from counts generated using the calendar 
year of 2014. 
 
Influenza surveillance data was collected from multiple sources, including sentinel outpatient health 
care providers, sentinel hospitals, public health, clinical laboratories, and schools. Laboratory-confirmed 
influenza cases were based on real-time polymerase chain reaction (RT-PCR) test results sent from SHL. 
SHL also surveyed clinical and reference labs throughout the state for the weekly number of rapid 
influenza tests performed and number of positives. Influenza-associated hospitalizations were reported 
from the sentinel hospitals that participated in the Iowa Influenza Surveillance Network (IISN).  
 
Respiratory syncytial virus (RSV) rapid antigen test data are used to determine the weekly positive 
predictive value of the rapid antigen tests in Iowa. SHL surveyed clinical and reference labs throughout 
the state for the number of rapid-antigen tests performed and number positive weekly, and sent the 
survey results to IDPH. 
 
The surveillance case definitions for HIV, AIDS, STDs, and TB are those developed through the 
collaboration of the Council of State and Territorial Epidemiologists (CSTE) and the Centers for Disease 
Control and Prevention (CDC). Surveillance is conducted according to detailed guidelines developed by 
CDC. Several programs enter data into CDC-developed software programs. Programs transfer de-
identified data via a secure data network on a weekly or monthly basis. HIV/AIDS data are collected in a 
CDC-developed software program called the enhanced HIV and AIDS Reporting System (eHARS). 
 
For accuracy of analysis, and because jurisdiction for HIV and AIDS cases is determined by the person’s 
residence at the time of diagnosis, great care is taken both within and between states to maintain 
unduplicated databases for HIV and AIDS. 
 
HIV/AIDS surveillance reports are generated annually and as needed. An integrated epidemiological 
profile for HIV, STD, and Hepatitis is produced every three years. HIV/AIDS data analysis for this report 
used a combination of CDC’s eHARS software, Microsoft® Excel, SAS®, and SAS® Enterprise Guide.  
 
In 2010, the STD program began using IDSS for surveillance of syphilis, chlamydia, and gonorrhea. Prior 
to 2010, the STD program entered data in a CDC database called STD*MIS or the STD Management 
Information System. 
 
Environmental Health Services began using IDSS in 2010 for surveillance of heavy metals (except lead), 
carbon monoxide, and methemoglobinemia. The results of all blood lead testing done on Iowa residents 
are required to be reported to IDPH utilizing electronic laboratory reporting. Reports are collected in a 
web-based database called the Healthy Homes and Lead Poisoning Surveillance System (HHLPSS), which 
went online in 2014. Data analysis is performed periodically for reporting to state and national partners. 
 
Most disease-specific data are transmitted to CDC electronically on a routine basis after being de-
identified. Some disease information is communicated at the request of CDC. The statistics reported by 
ADPER & EH programs to CDC are used to develop a composite picture of disease burden in the US.  
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Summary of respiratory and vaccine-preventable diseases 
 
Haemophilus influenzae B, invasive disease 
Cases of Haemophilus influenzae type B (Hib), invasive disease are rare in Iowa and the US today. In 
1991, Hib vaccine was recommended for all infants after age two months. Since then, the incidence of 
Hib in children less than five years of age has declined by more than 99 percent; in 2014, four cases of 
Hib were reported to IDPH.  
 
 
Hepatitis A 
See Summary Enteric Disease Section. 
 
 
Hepatitis B (acute and chronic) 
Hepatitis B is caused by infection with the Hepatitis B virus. Hepatitis B is usually spread when blood, 
semen, or another body fluid from a person infected with the Hepatitis B virus enters the body of 
someone who is not infected. This can happen through sexual contact with an infected person or 
sharing needles, syringes, or other drug-injection equipment. Household contacts of a case may also be 
exposed. Hepatitis B can also be passed from an infected mother to her baby at birth. 
 
Hepatitis B can be either acute or chronic. Acute hepatitis B virus infection is a short-term illness that 
occurs within the first six months after someone is exposed to the virus. Chronic hepatitis B virus 
infection is a long-term illness that occurs when the virus remains in a person’s body. Chronic hepatitis B 
is a serious disease that can result in long-term health problems and even death. 
 
A total of nine cases, or 0.3 cases for every 100,000 persons, of acute hepatitis B were reported to CADE 
in 2014. Females accounted for 56 percent of the cases. Nationally, acute hepatitis B infections occur 1.8 
times more often in men than in women.  
 
The Centers for Disease Control and Prevention (CDC) estimates there were 19,764 new hepatitis B 
infections in the US in 2013, and between 700,000 and 1.4 million people living with chronic hepatitis B 
disease in the US. 
 
There were 283 confirmed or probable chronic hepatitis B cases reported in 2014 in Iowa. Of these, 57 
percent were male and 43 percent were female.   
 
 
Influenza  
The Iowa Influenza Surveillance Network (IISN) tracks influenza activity, age groups impacted, outbreaks, 
virus type and strain, and severity of seasonal influenza. During the 2013-2014 season, more than 300 
surveillance sites reported to IISN, including medical clinics, hospitals, laboratories, schools, and local 
public health departments. IDPH analyzed the data reported from the surveillance sites and published 
the influenza weekly report during the season. To see the weekly report, visit 
www.idph.state.ia.us/IdphArchive/Archive.aspx?channel=FluReports. 
The 2014-2015 influenza season in Iowa started late and was more severe than in 2013-2014. The first 
case of seasonal influenza was confirmed by the State Hygienic Laboratory (SHL) in October, 2014. 
Influenza activity increased in November and peaked in the middle of December, 2014 (Figures 1-4). SHL 
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identified three seasonal influenza viruses circulating in Iowa for the season: influenza A (H3N2), 
influenza A (2009 H1N1) and influenza B (both Yamagata and Victoria Lineage). Influenza A (H3N2) 
viruses were predominant in Iowa, accounting for 78 percent of all positive influenza specimens tested 
(Figure 1). During the 2014-2015 season, 1,201 influenza-associated hospitalizations were reported from 
23 sentinel hospitals and 61 percent of the hospitalizations were among people 64 years-of-age and 
older (Figure 3). This is a 59 percent increase from the 491 influenza-associated hospitalizations 
reported during the 2013-2014 season (Figure 4). 
 
Figure 1. Laboratory-confirmed cases of influenza reported - Iowa, 2014-2015 
 
 
 
 
Figure 2. Percent of rapid influenza tests positive and number performed - Iowa, 2014-2015 
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Figure 3. Influenza-associated hospitalizations at sentinel hospitals by age - Iowa, 2014-2015 
 
 
Figure 4. Influenza-associated hospitalization rates at sentinel hospitals - Iowa, 2014-2015 
 
 
LEGIONELLOSIS 
The average number of Legionella cases reported to IDPH annually from 2011 to 2013 was 12 cases. 
There were 33 cases of legionellosis reported to IDPH in 2014. Cases ranged from ages 20 to 95 years 
with a median age of 55 years. All of the cases that occurred in 2014 were hospitalized. No outbreaks of 
legionellosis were identified in 2014. No deaths due to legionellosis were reported. 
 
  
Measles 
There were no cases of measles reported to IDPH in 2014. The last confirmed case in Iowa was in 2011 
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Meningococcal invasive disease 
There were two confirmed cases of meningococcal invasive disease reported to IDPH in 2014 (Table 2). 
The first case was in a child age 0-17 and was group B. The second case was in an adult 41-60 years of 
age and was group Y. Nationally, there were 556 cases reported in 2013. 
 
Table 2. Cases of meningococcal disease by serogroup - Iowa, 2014 
A B* C W135 Y Unk 
0 1 0 0 1 0 
*Serogroup B is not covered by the meningococcal vaccine 
 
CDC defines a community-based outbreak of meningitis as the occurrence of three or more confirmed or 
probable cases during a period of less than or equal to three months among persons residing in the 
same area, are not close contacts of each other, and do not share a common affiliation, with a primary 
attack rate of at least 10 cases per 100,000 persons2. There were no outbreaks in Iowa in 2014.  
 
Meningococcal invasive disease is fatal in 10-14 percent of cases; however, no Iowa case was fatal in 
2014. There are two types of meningococcal vaccines currently licensed for use in the US: a 
polysaccharide vaccine and a conjugated vaccine that cover strains A, C, W135, and Y. 
 
 
Mumps 
In 2014, there were 10 cases of mumps, or 0.3 cases per 100,000 persons. Case ages in 2014 ranged 
from 0 to 71 years, with a median age of 21 years. There were no outbreaks in Iowa in 2014. 
 
In 2006, Iowa was the center of the largest mumps outbreak in 20 years in the US with 1,963 confirmed 
and probable cases. Prior to 2006, most cases were typically imported from countries with endemic 
disease.  
 
 
Pertussis (Whooping cough) 
Pertussis is caused by Bordetella pertussis and before the vaccine era, typically caused epidemics every 
three to five years. In 2014, there were 222 confirmed and probable cases reported to IDPH, or 7.3 cases 
for every 100,000 persons in Iowa, as compared to 308 cases or 10.1 cases for every 100,000 persons in 
Iowa in 2013 (Figure 5). 
 
Children ages 0 to 14 accounted for 60 percent of cases in 2014. Of reported pertussis cases, 5 percent 
were hospitalized, and no deaths were reported. The year’s highest rates occurred in Decatur, Wayne, 
Winneshiek, Lucas, and Muscatine counties (Figure 6).  
 
The most common symptoms were paroxysms (fits of coughing, 84 percent) followed by post-tussive 
vomiting (51 percent), apnea (46 percent), and whooping (31 percent). Rare, but serious secondary 
conditions reported include pneumonia, seizures, and encephalopathy. 
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Figure 5. Pertussis cases reported by month and year - Iowa, 2005-2014 
 
 
Figure 6. Pertussis rates by county - Iowa, 2014 
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Respiratory Syncytial Virus (RSV) 
Sentinel surveillance for respiratory syncytial virus (RSV) began in 2008. IDPH and SHL solicit rapid RSV 
test results from clinical and reference labs throughout the state to determine the percentage of 
positive test results of those performed (Figure 7). In addition, various labs, including SHL, report 
polymerase chain reaction (PCR) or culture confirmation of RSV as a means to verify the presence of RSV 
in Iowa. The CDC considers RSV widespread in the population when the percent of rapid antigen tests 
that are positive exceeds 10 percent. During the 2014-2015 season in Iowa, this occurred in early 
December (week 50), and the activity peaked in Week 10 ending March 14, 2015. 
 
Figure 7. Percent of rapid RSV tests positive and number of tests performed - Iowa, 2014-2015 
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Tuberculosis (TB) 
In 2014, Iowa reported 54 cases of active TB disease. Since 2004, Iowa has averaged 46 cases of TB each 
year (Figure 8). Many cases have existing co-morbidities that make TB treatment considerably more 
complex and require extensive care, including the use of second-line drugs. Treatment with second-line 
drugs is complicated and expensive, requiring expert consultation and extended treatment durations.  
 
Figure 8. Number of TB cases by year - Iowa, 2005-2014 
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Counties with larger population centers such as Polk, Johnson, and Black Hawk, report the majority of TB 
cases. However, many (52/99) Iowa counties reported TB cases during calendar years 2005-2014 (Figure 
9). 
 
Figure 9. TB cases by county - Iowa, 2005-2014 
 
 
The 2014 TB case rate for Iowa was 1.75 cases per 100,000 persons, significantly lower than the 2014 
national average of 3.0 cases per 100,000 persons. Iowa owes its low TB case rate in part to proficient 
contact investigations, health care providers’ observance of treatment guidelines, adherence to directly 
observed therapy (DOT) for active disease cases, and the provision of medication for active TB disease 
and latent TB infection (LTBI) to approximately one thousand Iowans annually. 
 
The proportion of reported TB cases in non-US born persons has increased significantly in the past two 
decades. For example, in 1995 non-US born persons accounted for only 38 percent of reported TB cases 
in Iowa. From 2005 to 2014, non-US born persons accounted for 68 percent of reported TB cases in Iowa 
(Figure 10). Non-US born persons account for only four percent of the Iowa population, highlighting the 
disparity. The decreasing numbers of US born cases are due in part to effective TB control practices in 
this country. 
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Figure 10. Percent of US-born versus non-US born TB cases - Iowa, 2005-2014 
 
 
In many parts of the developing world, TB is still widespread and remains a leading cause of death. 
Immigration of people from these countries to the US illustrates how diseases in one part of the world 
can directly impact other parts of the world. Effective targeted testing programs for newly-arriving 
refugees, immigrants, and students play a major role in identifying and treating these populations and 
stopping the spread of TB in Iowa. 
 
In 2014, 38 individuals emigrating from 18 countries (excluding the US) developed TB in Iowa. A total of 
314 individuals, emigrating from 48 countries (excluding the US) developed TB disease after their arrival 
to Iowa during 2005 to 2014 (Figure 11). Approximately 95 percent of all patients with active TB disease 
live in the developing world, where 99 percent of all TB deaths occur. TB is a good example of the global 
nature of public health. It is important to implement consistent and aggressive public health measures 
everywhere to halt TB disease, which left untreated kills half of its victims. 
 
For a detailed overview of TB, see www.idph.state.ia.us/ImmTB/TB.aspx?prog=Tb&pg=TbHome. 
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Figure 11. TB cases by country of origin - Iowa, 2005-2014 
 
 
 
Summary of HIV and AIDS and hepatitis C 
 
HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND ACQUIRED IMMUNODEFICIENCY 
SYNDROME (AIDS) 
There were 99 HIV diagnoses in 2014, down 23 (19 percent) from 122 diagnoses in 2013, and 21 (18 
percent) below the average of 120 for the previous five years (2009-2013). Nonetheless, this fits the 10-
year pattern of variability seen since 2005 (Figure 12). During that 10-year period, annual diagnoses 
ranged from a low of 99 to a high of 126, with an average of 114.2 and median of 115.5. In 2014 there 
were 3.2 HIV diagnoses per 100,000 persons, compared to 4.0 HIV diagnoses per 100,000 persons in 
2013 and 3.8 HIV diagnoses per 100,000 persons in 2012. 
 
Figure 12. HIV diagnoses by year - Iowa, 2005-2014 
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A person who is diagnosed with AIDS within 12 months of initial HIV diagnosis is termed a “late tester.” 
Given this definition (it takes a year to determine), 2013 is the most recent year for which complete late 
tester analysis is available. After peaking at 61 percent in 2001, late testers as a proportion of all HIV 
diagnoses for a given year declined over time to 35 percent in 2011, only to climb again to 39 percent in 
2012 and 48 percent in 2013. Late testers have typically been infected for many years and during that 
time have had the opportunity to unknowingly infect others with the virus. They generally have higher 
HIV viral loads and are more infectious than are persons who have been diagnosed early, are in care, 
and have a very low viral load as the result of successful treatment with antiretroviral medications.  
 
Diagnoses of HIV among the foreign born reached a 10‐year high in 2010, when 28 (24 percent) of the 
119 persons diagnosed with HIV in Iowa were born outside the U.S. Foreign-born persons accounted for 
19 percent of total HIV diagnoses in the last five years (2009-2013) and 18 percent in 2014. Diagnoses 
among foreign-born persons in Iowa may not necessarily indicate new diagnoses. By CDC rules, foreign-
born HIV-infected persons who initially immigrated to Iowa (refugees, spouses, or other types of 
immigrants) are counted as Iowa diagnoses even if they had an initial diagnosis in their country of origin. 
While IDPH does not monitor the immigration status of persons diagnosed with HIV, resettlement of 
refugees in Iowa and secondary migration of immigrants from areas of the world with higher prevalence 
of HIV may be contributing to diagnoses among the population of foreign-born. US-born persons have 
accounted for 88 percent of total HIV diagnoses in Iowa, on average, since the beginning of the 
epidemic. 
  
Males have accounted for 82 percent of HIV diagnoses among Iowans since the beginning of the 
epidemic. This disparity has remained constant in the short term, with 81 percent of HIV diagnoses 
among males during the five years from 2009 through 2013 and 80 percent (79 diagnoses) in 2014. 
Diagnoses among females fell to 20 in 2014 after spiking at 34 and accounting for 28 percent of 
diagnoses in 2013. The 20 cases in 2014 are consistent with the average of 20 from 2006 through 2012. 
Thus, year-to-year variations notwithstanding, there continues to be about four diagnoses among males 
for every one diagnosis among females.  
 
Over half of all HIV diagnoses annually were among persons 25 to 44 years of age, except in 2013 and 
2014, when diagnoses in this group fell to 44 percent and 45 percent of diagnoses, respectively. Persons 
25 to 44 years of age have accounted for 64 percent of all HIV diagnoses in Iowa since the beginning of 
the epidemic; however, they accounted for only 51 percent of diagnoses in the last five years (2009-
2013). HIV diagnoses among persons aged 45 years and older reached a peak of 50 (41 percent) of the 
122 total diagnoses in 2013, but fell to 34 (34 percent) of 99 diagnoses in 2014. While persons aged 45 
years and older have accounted for 22 percent of total HIV diagnoses, on average, since the beginning of 
the epidemic, they accounted for 29 percent of diagnoses in the last five years (2009-2013). Diagnoses 
among persons aged 15 to 24 years peaked at 27 (23 percent) in 2011, averaged 22 (18 percent) for the 
five years 2009 through 2013, and numbered 18 (18 percent) in 2014. There were two pediatric HIV 
diagnoses in 2014. One was a foreign-born child initially diagnosed and treated outside the US. 
 
For persons 13 years of age and older (adults and adolescents), mean and median ages at diagnosis in 
2014 were 38.6 and 37.0 years respectively, slightly higher than the five-year (2009-2013) mean of 37.5 
years and median of 36.7 years. In 2014, the ages for adult/adolescent males, 38.7 (mean) and 37.0 
years (median), were almost the same as those for adult/adolescent females, 38.4 (mean) and 37.5 
years (median).  
  
Racial and ethnic minorities continue to be over-represented in HIV diagnoses (Figure 13). HIV diagnoses 
among non‐Hispanic black/African-American persons decreased from 26 (21 percent) in 2013 to 12 (12 
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percent) in 2014, half the five-year (2009-2013) average of 24. Of the 12 black/African-American persons 
diagnosed in 2014, three (25 percent) were foreign born, compared to 12 (46 percent) of the 26 
black/African-American persons diagnosed in 2013. Black/African-American persons make up almost 
three percent of Iowa’s population, but have account for 20 percent of HIV diagnoses over the last five 
years (2009-2013) and 15 percent of HIV diagnoses in Iowa since the beginning of the epidemic. The 12 
non‐Hispanic black/African-American diagnoses in 2014 equate to 12.4 diagnoses per 100,000 
non‐Hispanic black/African-American persons. 
 
HIV diagnoses among Hispanic persons increased from nine (7 percent) in 2013 to 11 (11 percent) in 
2014. Of the 11 Hispanic persons diagnosed in 2014, nine (82 percent) were foreign-born, compared to 
six (67 percent) of the nine Hispanic persons diagnosed in 2013. Hispanic persons make up about 5 
percent of Iowa’s population, but have accounted for 8 percent of total HIV diagnoses over the five 
years 2009 through 2013, and 7 percent of all HIV diagnoses in Iowa since the beginning of the 
epidemic. The 11 Hispanic diagnoses in 2014 equate to 6.5 per 100,000 Hispanic persons.  
 
Numbers of HIV diagnoses among non-Hispanic Asians in Iowa are small and primarily influenced by 
immigration. All non-Hispanic Asian HIV diagnoses since 2005 have been among foreign-born people, 
except in 2009 when two of the seven diagnoses were among U.S.-born Asian people. Diagnoses among 
non-Hispanic Asians reached a peak in 2013 at eight (7 percent) of the 122 diagnoses. Only one non-
Hispanic Asian was diagnosed with HIV in 2014, equating to 1.6 diagnoses per 100,000 non-Hispanic 
Asian persons. Non-Hispanic Asian persons make up two percent of Iowa’s population, but have 
accounted for five percent of HIV diagnoses in the last five years (2009-2013) and two percent of all HIV 
diagnoses in Iowa since the beginning of the epidemic. 
  
Despite the racial and ethnic disparities noted above, the largest proportion of HIV diagnoses in Iowa 
continued to be among non‐Hispanic, white persons. Of the 99 HIV diagnoses in 2014, 68 (69 percent) 
were among non‐Hispanic, white persons compared to a five-year (2009-2013) average of 63 percent. 
Since the beginning of the epidemic, non‐Hispanic, white persons have accounted for 74 percent of all 
new HIV diagnoses in Iowa. The 68 non‐Hispanic, white persons diagnosed in 2014 equate to 2.5 per 
100,000 non-Hispanic, white persons.  
 
When the numbers of persons diagnosed per 100,000 persons are compared, non‐Hispanic 
blacks/African Americans were five times more likely to have been diagnosed with HIV in 2014 than 
non‐Hispanic whites. Hispanic persons were 2.6 times more likely to have been diagnosed with HIV in 
2014 than non‐Hispanic, white persons. 
 
Figure 13. HIV diagnoses by race and ethnicity - Iowa, 2014 
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Men who have sex with men (MSM) remained the leading exposure category for HIV infection in Iowa. 
Of the 99 HIV diagnoses in 2014, 55 (56 percent) were among MSM, less than the five-year (2009-2013) 
average of 67. MSM accounted for 56 percent of five-year (2009-2013) HIV diagnoses and 56 percent of 
all HIV diagnoses since the beginning of the epidemic.  
 
Numbers (and proportions) of other HIV exposure categories in 2014 were as follows: injection drug use 
(IDU), six (6 percent); men who have sex with men and inject drugs (MSM/IDU), two (2 percent); 
heterosexual contact, 20 (20 percent); and no identified risk (NIR), 14 (14 percent). Experience has 
shown that while newly-diagnosed persons may initially be reluctant to disclose their mode of HIV 
exposure to their health care provider or to health department staff, they become less reticent as they 
come to trust their providers. Some exposures will be ascertained over time through follow-up calls to 
care providers. By the end of 2015, exposure category will have been ascertained for most of the 
remaining persons diagnosed in 2014. As noted above, there were two pediatric HIV diagnoses in 2014. 
One of these was born and first diagnosed and treated in a foreign country.  
  
A total of 60 persons were diagnosed with AIDS in 2014, down from 82 in 2013 and 91 (the highest 
number since 1996) in 2009. The 60 AIDS diagnoses in 2014 are lower than the average of 78 for the five 
years 2009 through 2013.  
 
The number of deaths among HIV-infected persons diagnosed in Iowa continues to decrease since 
peaking at 103 deaths in 1995. Death numbers have fluctuated from a low of 23 to a high of 37 since 
2000. As of December 31, 2014, a total of 1,177 deaths have been reported among HIV-infected persons 
in Iowa. Of those deaths, 67 percent were caused in some part by the underlying HIV disease, 29 
percent of deaths were not HIV-related, and the cause of 4 percent is unknown. Death data for 2014 are 
incomplete. The underlying cause for the 23 deaths already reported for 2014 has yet to be officially 
certified. Matching eHARS to the State Death Registry and the National Death Index in late summer of 
2015 will provide more complete data. 
  
The number of HIV-infected persons residing in Iowa at the end of 2014 was 2,369, a prevalence of 77 
per 100,000 people. This number includes persons initially diagnosed in Iowa (and still living in Iowa), 
plus people who were initially diagnosed while living in another state but who now reside in Iowa. As of 
December 31, 2014, 96 of Iowa’s 99 counties had at least one person living with HIV disease. Prevalence 
in four counties was greater than 100 per 100,000 persons. Polk County, with 149 per 100,000 topped 
the list, followed by Pottawattamie County with 146 per 100,000, Scott County with 113 per 100,000, 
and Johnson County with 109 per 100,000.  
  
In Figure 14 (below), Persons Living With HIV (PLWH) is defined as persons diagnosed with HIV disease 
as of December 31, 2013, and living in Iowa at the end of 2014. “Retained in Care” is defined as PLWH 
having two or more CD4 or viral load lab results at least three months apart or having one CD4 or viral 
load lab result and virally suppressed during 2014. “Viral Suppression” is defined as persons retained in 
care and virally suppressed (viral load < 200 copies/mL) at the end of 2014. At the end of 2014, 1,655 (72 
percent) of the 2,295 PLWH in Iowa were retained in care, and 1,552 (94 percent) of them were virally-
suppressed. Viral suppression for all PLWH (in care and out of care) was 68 percent. Studies have shown 
viral suppression optimizes individual health outcomes, and may reduce the likelihood of transmitting 
HIV by 96 percent. 
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Figure 14. Continuum of HIV care - Iowa, 2014 
 
 
 
Hepatitis C 
Hepatitis C is the most common chronic blood-borne pathogen in the United States. According to the 
Centers for Disease Control and Prevention (CDC) there are an estimated 2.7 to 3.9 million people living 
with chronic hepatitis C in the United States. According to the 2014 census population estimate for 
Iowa, there were 3,107,126 people residing in the state. CDC estimates that 1.3 percent to 1.9 percent 
of the state’s population, or 40,392 to 59,035 Iowans, have potentially been infected with the Hepatitis 
C virus.  
 
Hepatitis C data are collected using IDSS, the state’s web‐based reporting system, to allow for collection 
of risk information, test results, referral information, and data on whether immunizations were offered. 
 
Summary of sexually transmitted diseases 
 
The Bureau of HIV, STD, and Hepatitis is responsible for tracking the incidence of sexually transmitted 
diseases, including chlamydia, gonorrhea, and syphilis. In addition to disease surveillance, IDPH supports 
targeted voluntary screening at 65 public sites throughout Iowa. IDPH also works with private health 
care providers to increase screening. 
 
IDPH provides free treatment to eligible individuals at public testing sites who test positive for 
chlamydia, gonorrhea, syphilis, or trichomoniasis. Sexual partners can be treated as well. In 2008, Iowa 
Code 139A was updated to allow for expedited partner therapy (EPT). This statute allows health care 
practitioners to give medications or prescriptions for the treatment of chlamydia or gonorrhea to their 
patients to give to exposed partners, particularly when the partner is unable or unwilling to come in to a 
clinic for examination. These medications may also be distributed to exposed partners via public health 
professionals. 
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CHLAMYDIA 
Urogenital infections caused by Chlamydia trachomatis are extremely common in some populations. In 
fact, chlamydial infections account for the greatest number of cases of any reportable disease in the 
United States and in Iowa. Diagnoses of chlamydia have increased steadily during the past couple 
decades. The reasons for this increase are varied. One important reason is that testing technology has 
improved, allowing for more sensitive tests and more convenient ways to test. The use of nucleic acid 
amplification tests (NAATs) for the detection of Chlamydia trachomatis became widespread in Iowa in 
the mid-2000s. This method of detection is much more sensitive than the previously used method of cell 
culture. NAATs also permit the use of a greater variety of specimen types. Urine and vaginal specimens 
(which can be collected much less invasively than the traditional specimen types of cervical and 
urethral) can be used for NAATs. Because most chlamydial infections cause no symptoms, there is a 
large pool of undiagnosed chlamydia in certain populations. As testing methodology has improved and 
as screening has increased, the number of cases reported has also increased.  
 
In 2014, 11,807 cases of chlamydia were reported to IDPH (Figure 15). This corresponds to a rate of 388 
cases per 100,000 persons. Iowa is lower than the US average of 447 cases per 100,000 persons. Both 
nationally and in Iowa, adolescents and young adults are the most impacted populations. In Iowa, 67 
percent of reported infections occurred in persons 15 to 24 years of age. 
 
There are racial and ethnic disparities among those infected with chlamydia. Although black, non-
Hispanic persons accounted for 3 percent of the population in Iowa, 18 percent of chlamydial infections 
were diagnosed in this population. According to national data from CDC3, Iowa ranks number one in the 
nation for the rate of chlamydia among black, non-Hispanic populations in the US. 
 
Figure 15. Cases of chlamydia and gonorrhea by year - Iowa, 2004-2014 
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GONORRHEA 
Nationally, the number of reported cases of gonorrhea has been fairly steady over the past several 
years. On average, the trends in Iowa have mirrored this, although 2014 data indicate an increase. 
NAATs have been utilized for gonorrhea as they have been for chlamydia. The most widely used tests 
incorporate gonorrhea and chlamydia testing into a single specimen collection. Thus, patients are 
typically tested for both infections simultaneously.  
 
In 2014, 1,641 cases of gonorrhea were reported to IDPH (Figure 15), which corresponds to 54 cases per 
100,000 persons. This is well below the national average of 106 cases per 100,000 persons. Gonorrhea 
has many similarities with chlamydia, chief of which is the population (i.e., adolescents/young adults) 
that it predominately affects. Those aged 15 to 24 years of age accounted for 54 percent of reported 
cases in Iowa. Black, non-Hispanic persons are even more disproportionately affected by gonorrhea than 
they are by chlamydia in Iowa. Black persons accounted for 35 percent of reported cases (Figure 16).  
 
Antimicrobial resistance is of continuing concern with Neisseria gonorrhoeae. The only class of 
antimicrobials still effective in the treatment of gonococcal infection is the cephalosporins. 
Antimicrobials in other classes possess insufficient efficacy to cure the infection on their own. Current 
guidelines recommend dual therapy of ceftriaxone with azithromycin4. Dual therapy is recommended 
because individuals infected with gonorrhea are often co-infected with chlamydia. Furthermore, dual 
therapy likely slows the development of resistance to cephalosporins. Treatment failures with the last 
remaining effective oral cephalosporin have been confirmed in North America5. It is anticipated that N. 
gonorrhoeae will develop resistance to all cephalosporins, at which time treatment will become much 
more difficult. Currently, no new antimicrobials are available to treat gonorrhea. Researchers are 
investigating the use of other drug combinations to cure gonococcal infections but it is unknown if and 
when new options will be available for population-wide clinical use. 
 
The significant disparities among black populations, the likelihood of further antimicrobial resistance by 
N. gonorrhoeae, and the steady number of cases make improving gonorrhea prevention a priority for 
IDPH and CDC. 
 
Figure 16. Gonorrhea cases by race - Iowa, 2014 
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SYPHILIS 
Iowa is considered a low-morbidity state for syphilis; however, the number of reported cases has 
significantly increased over the last three years (Figure 17). In 2014, 239 cases of syphilis were reported 
to IDPH. Of these, 154 were cases of early syphilis (primary, secondary, or early latent), which are of 
greatest concern to the public’s health because these are the infectious stages of the disease. In 2014, 
the rate of early syphilis in Iowa was 5.1 per 100,000 persons, which is less than the US average of 10.9 
per 100,000 persons. The preponderance of syphilis cases occurred in men. In terms of early syphilis, 89 
percent of cases were among men. Of these, the majority were men who have sex with men (MSM). Co-
infection with HIV is a concern with this population, so concurrent testing for HIV is recommended for 
persons at risk for syphilis. 
 
Elimination of syphilis from Iowa has proven difficult due to sporadic clusters of cases and the spread 
from other states. The more recent outbreak among Iowa’s MSM populations have complicated 
elimination efforts further, with challenging investigations and inadequate resources being significant 
contributing factors. IDPH follows up on every case of syphilis in Iowa and ensures that partner services 
and treatment are offered whenever they are appropriate and possible.  
 
Figure 17. Syphilis cases by year - Iowa, 2005-2014 
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Summary of enteric diseases 
 
Campylobacteriosis 
The total number of Campylobacter cases reported in 2014 was 571. Campylobacteriosis incidence was 
18.7 cases for every 100,000 people in 2014. 
Campylobacteriosis activity typically peaks in early summer (Figure 18). Consumption of raw or 
undercooked meat, raw milk, contaminated water, and contact with infected animals are common 
sources of Campylobacter infection.  
Figure 18. Campylobacteriosis cases by month and year - Iowa, 2012-2014 
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Cryptosporidiosis 
There were 264 cases of cryptosporidiosis reported in Iowa in 2014, or 8.7 cases per 100,000 people 
(Figure 19). This is a decrease from 2013, when there were 1,505 cases reported in Iowa (49.4 cases per 
100,000 people). No outbreaks of cryptosporidiosis were identified in 2014. 
Cryptosporidiosis (often called crypto) is a diarrheal disease caused by a protozoan called 
Cryptosporidium parvum. The parasite can cause disease in both animals and humans. People usually 
catch cryptosporidiosis by coming in contact with persons or animals shedding the parasite, or drinking 
contaminated water. 
Figure 19. Cryptosporidiosis cases by month and year - Iowa, 2012-2014 
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E. coli O157:H7 and other shiga-toxin producing strains 
The incidence of E. coli shiga-toxin cases in Iowa increased slightly from 5.6 cases per 100,000 persons in 
2013 to 7.4 cases per 100,000 persons in 2014 (Figure 20). There were 224 total cases reported in 2014. 
Most types of E. coli are harmless and live in the gut, but some E. coli, including O157:H7, can cause illness. 
E. coli is spread by a person eating or drinking food or water that was contaminated with feces from 
infected people or animals. Other sources of E. coli include consumption of raw milk, unpasteurized cider 
or other juices, or poorly cooked meat. 
Figure 20. E. coli O157:H7 and other shiga-toxin producing strain cases by month and year - Iowa, 
2012-2014 
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Giardiasis 
Giardiasis activity typically peaks in late summer or early fall (Figure 21). In 2014, there were 205 cases 
reported in Iowa. There were 6.7 cases for every 100,000 persons in 2014 compared to 9.0 cases for 
every 100,000 persons the previous year.  
 
Giardiasis is a diarrheal disease caused by the microscopic parasite Giardia, a parasite that lives in the 
intestines of people and animals. Giardia is one of the most common causes of waterborne disease in 
the United States. The parasite can be found in streams, lakes, wells, and recreational waters. 
 
Figure 21. Giardiasis cases by month and year - Iowa, 2012-2014 
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Hepatitis A 
In 2014, 12 cases of hepatitis A were reported in Iowa (Figure 22). The three-year average from 2011-
2013 was 11 cases. Cases ranged in age from 20 to 62 years of age. None of the cases were associated 
with outbreaks. 
 
Hepatitis A is a highly contagious liver disease caused by the hepatitis A virus. It is usually transmitted by 
the fecal-oral route, either through person-to-person contact or consumption of contaminated food or 
water. 
 
Figure 22. Hepatitis A cases by month and year - Iowa, 2012-2014 
 
 
 
Listeriosis 
There were seven cases of Listeria monocytogenes reported in 2014. None were associated with a 
national outbreak. 
 
Listeriosis is an uncommon bacterial infection caused by the bacteria Listeria monocytogenes. This 
bacterium is widespread in nature and most cases are sporadic, although foodborne outbreaks and 
person-to-person spread have been documented. L. monocytogenes is most commonly found in the soil, 
water, mud, cattle forage, and silage. Infected humans and animals can also shed the bacteria. 
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Salmonellosis 
Salmonellosis incidence in 2014 decreased to 17.3 cases per 100,000 persons from 18.9 cases per 
100,000 persons in 2013 (Figure 23). The total number of cases reported was 527. Local public health 
departments and IDPH investigated one Iowa-specific outbreak, which was associated with a restaurant. 
IDPH also interviewed several Iowans involved in national Salmonella investigations. 
Figure 23. Salmonellosis cases by month and year - Iowa, 2012-2014 
 
 
 
  Shigellosis 
In 2014, 208 cases of Shigella were reported in Iowa, down from 342 cases reported in 2013 (Figure 24). 
There were no newly identified outbreaks of Shigella in 2014, though the beginning of the year saw 
increased numbers of cases likely associated with the large community-wide outbreak in western Iowa 
that occurred towards the end of 2013. 
 
Figure 24. Shigellosis cases by month and year - Iowa, 2012-2014  
 
 
 
Iowa Department of Public Health 
 34 
Summary of zoonotic and vectorborne diseases 
 
Dengue fever 
In 2014, four cases of Dengue fever were reported to IDPH. Cases ranged from age 19 to 52 with a 
median age of 23 years. All infections were acquired outside of the United States. 
 
 
CHIKUNGUNYA 
In 2014, four cases of chikungunya virus disease were reported in Iowa. Chikungunya is not found in 
Iowa. All infections were acquired outside of the continental United States. 
 
 
Ehrlichiosis/Anaplasmosis 
There are at least three species of bacteria responsible for ehrlichiosis/anaplasmosis in the United 
States: Ehrlichia chaffeensis, Anaplasma phagocytophilum, and Ehrlichia ewingii. They are transmitted 
by the bite of an infected lone star tick (Amblyomma americanum), which is found in Iowa. The clinical 
signs and symptoms of these infections are similar.  
 
In 2014, there were 17 cases of ehrlichiosis/anaplasmosis reported to IDPH, an increase from the eight 
cases reported in 2013.  
 
 
Hantavirus 
There were two reports of hantavirus pulmonary syndrome (HPS) in Iowa in 2014. There have been 11 
cases of HPS reported in Iowa since the disease was first identified in 1993. Substantial rodent exposure 
has been identified in most of these cases. 
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Lyme disease 
Lyme disease is caused by Borrelia burgdorferi and is transmitted to humans by the bite of an infected tick, 
primarily the blacklegged tick. Symptoms of Lyme disease can include fever, headache, fatigue, and a 
“bull’s-eye” skin rash also known as erythema migrans. In 2014, 194 cases of Lyme disease were reported 
to IDPH, a decrease from 2013 but a 13 percent increase over the previous three-year average (Figure 25). 
The 2014 Iowa case rate for Lyme disease was 6.2 cases per 100,000 persons. Most cases occurred in the 
eastern half of the state (Figure 26). 
 
Figure 25. Confirmed and probable Lyme disease cases by year - Iowa, 2005-2014 
 
 
Figure 26: Confirmed and probable Lyme disease cases by county - Iowa, 2014 
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Malaria 
In 2014, 17 cases of malaria were identified in Iowa, an increase from the 12 cases reported in 2013. 
Cases ranged from ages two to 56, with a median age of 26 years. All infections were acquired outside of 
the United States. 
 
 
Rabies, Animal 
In 2014, 15 cases of animal rabies were reported in Iowa, which is slightly higher than the number 
identified in 2013. Rabies was identified most frequently in wildlife species, including 10 bats and two 
skunks. Two cases were diagnosed in cows and one case was diagnosed in a cat; however, only animals 
that have exposed humans are tested for rabies. 
 
During 2014, 1409 animals in Iowa were tested for rabies and 15 were confirmed positive (1.06 percent). 
The percent positive varies greatly by species (Table 3). It is important to note that this data is greatly 
influenced by the number of animals tested. Many animals are tested because they have contact with 
humans or domestic animals and they exhibit unusual behavior or clinical signs, making them more 
likely to be infected with the rabies virus. For these reasons, the percentages should not be considered 
representative of the true distribution of disease within the animal population in Iowa. 
 
Table 3. Animals testing positive for rabies virus by species - Iowa, 2014 
Species Positive Total Tested Percent Positive 
Bat 10 487 2.05% 
Skunk 2 7 28.57% 
Cow 2 82 2.44% 
Cat 1 366 0.27% 
 
There are two rabies strains that commonly circulate in Iowa (bat and skunk) and many different species 
can be infected with these strains. In animal samples that are strongly positive for rabies, the State 
Hygienic Laboratory (SHL) can differentiate the rabies strain that infected the animal (the strain typing 
procedure is only effective in samples that are strongly positive as opposed to weakly positive) (Table 4). 
In 2014, SHL was able to identify the rabies strain in seven of the positive rabies cases; four were bat 
strain and three were skunk strain. Bat strain rabies was identified in four bats. Skunk strain rabies was 
identified in two skunks and one cow. For more information on rabies, visit 
www.idph.state.ia.us/Rabies/Resources.aspx. 
 
Table 4. Animals testing positive for rabies virus by species and by year - Iowa, 2005-2014 
Species 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 
Bat 60 28 13 11 11 10 12 17 6 10 
Skunk 33 13 5 7 13 13 7 9 4 2 
Cat 5 7 7 9 3 1 3 1 0 1 
Cow 7 4 0 1 5 1 3 4 2 2 
Dog 2 2 5 1 2 1 0 0 0 0 
Horse 1 3 1 0 0 0 0 0 0 0 
Fox 0 0 0 0 0 1 0 0 0 0 
Squirrel 0 0 0 0 1 0 0 0 0 0 
Badger 0 0 0 0 0 0 0 0 0 0 
Total 108 57 31 29 35 27 25 31 12 15 
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Rabies, Human 
Iowa’s most recent human rabies case occurred in 2002 and was caused by bat strain rabies. Prior to 
that, the last reported human case in Iowa occurred in 1951.  
  
While the exact number of people who receive rabies post-exposure prophylaxis each year in the United 
States is unknown, it is estimated to be about 40,000 people. Based upon Iowa’s population, it is 
estimated that approximately 400 Iowans receive rabies post-exposure prophylaxis each year.  
 
 
Rocky Mountain Spotted Fever (RMSF) 
In 2014, 10 cases of Rocky Mountain spotted fever (RMSF) were reported in Iowa. American dog ticks 
are carriers of Rickettsia rickettsii, the bacteria that causes RMSF. The American dog tick is the most 
common species of tick in Iowa and can be found in every county in the state. The tick is most active late 
March through August. Iowa RMSF cases in 2014 had symptom onset dates from May to October. Cases 
ranged from ages 26 to 60, with a median age of 46. Nine out of the 10 cases were male. 
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West Nile Virus 
There were 15 human cases of West Nile virus reported to IDPH in 2014, a decrease from the 44 cases 
reported in 2013 and 31 cases reported in 2012 (Table 5). Eight of the 15 cases reported in 2014 were 
hospitalized (53 percent), and no deaths were reported. Cases ranged from age two to 76, with a 
median age of 45. Eight cases were male and seven were female. The highest numbers of cases were 
reported in the northwest region of the state (Figure 27).  
 
Table 5. West Nile virus activity by species and outcome - Iowa, 2005-2014
  2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 
Human cases 37 37 30 5 5 9 9 31 44 15 
Human deaths 2 0 3 1 0 2 0 0 0 0 
Sentinel chickens 19 18 18 3 6 14 14 17 15 * 
Mosquito (pools) 7 15 5 5 9 7 5 14 66 15 
Horses 15 12 10 4 3 2 1 35 11 5 
*Sentinel chicken testing was not performed 
 
Figure 27. Human West Nile virus cases by county - Iowa, 2014 
 
 
 
 
 
 
 
 
 
 
Divisions of Acute Disease Prevention and Emergency Response, Environmental Health, and Behavioral Health 
39 
 
Summary of Rare and Unusual Diseases 
 
Toxic Shock Syndrome 
There was one case of Toxic Shock Syndrome reported to IDPH in 2014, which occurred in a male child 
(0-17 years of age).   
 
Tularemia 
There was one case of tularemia reported to IDPH in 2014, which occurred in a female (61-80 years of 
age). 
 
There were no cases of human illness reported for the following diseases: 
Hansen’s disease (Leprosy) 
Hepatitis E 
Psittacosis 
Tetanus 
Yellow Fever 
 
Changes to the reportable disease list are set to take affect January 2016.  
The following will be removed from the reportable disease list: Enterococcus invasive disease, Group A 
Streptococcus invasive disease, Streptococcus pneumoniae invasive disease, Toxic Shock Syndrome, 
Trichinosis, and Staphylococcus aureus invasive disease: Methicillin-resistant invasive disease.   
 
The following will be added to the reportable disease list: Tularemia, Q Fever, exposure to harmful algal 
blooms. 
 
Clarifications will be made to the reporting language for mosquito-borne diseases, tick-borne diseases, 
and viral hemorrhagic fevers. 
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Summary of environmental health conditions 
 
Carbon Monoxide (CO) Poisoning 
Each year, according to the CDC, more than 400 Americans die from unintentional CO poisoning.  
Additionally, more than 20,000 visit the emergency room and more than 4,000 are hospitalized due to 
CO poisoning. Fatalities are highest among Americans 65 and older. IDPH collects reports of CO 
poisoning and CO exposure from health care providers and the Iowa Statewide Poison Control Center 
(Table 6). CO poisoning is defined in Iowa as: 
 A blood carbon monoxide level equal to or greater than 10 percent carboxyhemoglobin or its 
equivalent with a breath analyzer test; or 
 A clinical diagnosis of carbon monoxide poisoning regardless of any test result.  
 
Table 6. Carbon monoxide poisoning cases by gender - Iowa, 2014 
Gender Number of Cases 
Male 17 
Female 17 
Total 34 
 
Information collected includes basic demographics (age, gender, county of residence), diagnosis, blood 
carboxyhemoglobin test results, exposure (circumstance, source, location) (Figure 28), and severity of 
health impact (Figure 29). Reports are reviewed to identify clusters and possible occupational exposures 
for further investigation and intervention. 
 
In 2014, there was one reported death from CO exposure in Iowa. Thirty-four individual reports of CO 
poisoning were received by IDPH. 
 
Figure 28. Sources of exposure among cases of carbon monoxide poisoning - Iowa, 2014  
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Vehicles include automobiles and other fuel-powered recreational vehicles (e.g. boats, ATVs, Zamboni Ice Resurfacing machines, etc.). 
Fixed appliances include fuel-burning equipment that is typically stationary (e.g., furnaces, gas water heaters, gas stoves or fireplaces). 
Mobile appliances include generators, space heaters, and other small power equipment (e.g., power washers, lawn mowers, chainsaws, etc.) 
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Figure 29. Severity of health impact among cases of carbon monoxide poisoning - Iowa, 2014 
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Fatal – Patient died due to carbon monoxide poisoning 
Major – Patient experienced major symptoms (loss of consciousness, long-term complications) 
Moderate – Patient experienced moderate symptoms such as nausea, vomiting, confusion 
Minor – Patient experienced minor symptoms such as headache, dizziness 
 
 
Methemoglobinemia 
Methemoglobinemia is a blood disorder caused when nitrite interacts with the hemoglobin in red blood 
cells, reducing the ability to carry sufficient oxygen to individual body cells. Infants under six months of 
age are the primary population at risk, and the condition is also known as ‘Blue Baby Syndrome.’ Sources 
of nitrite include nitrate in drinking water or from preservatives in food, some drugs, or other sources. 
 
In 2014, there were two cases of methemoglobinemia reported in Iowa. There were no cases reported 
in an infant. 
 
 
Heavy Metal Poisoning (Non-Lead) 
IDPH conducts surveillance for three other heavy metals in addition to lead: arsenic, cadmium, and 
mercury. Cases of poisoning from these three heavy metals are rare in Iowa and many exposures are 
related to industrial or hobby/small market work in industries that use these metals. Outside of 
industrial use, the possibility of arsenic contamination of moonshine, herbal preparations, and 
nutritional supplements also must be considered as a source of exposure. Other potential sources of 
mercury exposure include consumption of large amounts of contaminated fish and seafood, or from 
broken thermometers, barometers, fluorescent light bulbs, or electrical switches. In 2014, there were 
three cases of arsenic poisoning, one case of cadmium poisoning, and three cases of mercury poisoning 
reported. 
 
 
Childhood lead poisoning 
Lead has adverse effects on nearly all organ systems in the body. It is especially harmful to the 
developing brains and nervous systems of children under the age of 6. At very high blood lead levels, 
children can have severe brain damage or even die. Recent research suggests that there is no level of 
lead exposure at which adverse health and developmental effects do not occur. At blood lead levels as 
low as 1 microgram per deciliter (μg/dL), children’s intelligence, hearing, and growth may be affected. 
This damage can be minimized if a child’s lead exposure is reduced; however, the damage cannot be 
reversed. The Centers for Disease Control and Prevention recommends that public health actions be 
initiated at blood lead levels above 5 µg/dL, and has a goal to eliminate blood lead levels greater than or 
equal to 10 µg/dL in children. 
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Iowa's children are most commonly poisoned by lead‐based paint found in homes built before 1950. 
Lead‐based paint in a home becomes a lead hazard as it deteriorates and paint chips end up on the 
floors and in window wells throughout the home, as well as in the soil around the exterior of a home. 
Since 2008, Iowa law has required that all children have proof of a blood lead test when enrolling in 
kindergarten. The Iowa Department of Public Health recommends that children receive a blood lead test 
at least every year, starting when they are one year old, until six years of age. Depending upon the 
results of the blood lead testing, more frequent testing may be recommended. 
 
There are two types of specimens for blood lead tests completed in Iowa: a finger or heel stick (capillary 
test) and blood drawn from a vein (venous test). The venous test is more accurate, and is required to 
confirm the result of an abnormal capillary test result of 10 µg/dL or greater. There were 60,653 blood 
lead tests completed on children under the age of six in Iowa in 2014. Of these 60,653 tests completed 
in Iowa, 1,070 (1.7 percent) blood lead tests were at levels at or above the 10 µg/dL level (Table 7). 
There were 521 confirmatory elevated blood lead level tests in 2014. A confirmed elevated blood lead 
level is defined as 1) any venous blood level test result greater than or equal to 10 µg/dL, or 2) a set of 
two capillary blood lead test results greater than or equal to 10 μg/dL conducted less than 12 weeks 
apart. There were 491 unconfirmed elevated blood lead level tests in 2014. An unconfirmed elevated 
blood lead level is any capillary blood lead test result greater than or equal to 10 μg/dL that is not 
confirmed by a follow-up capillary or venous blood lead test within 12 weeks. 
 
Table 7. Children with elevated blood lead levels by highest confirmed level - Iowa, 2014 
Blood Lead 
Level Range 
Number of Confirmed 
Elevated Blood Tests 
Percent of Confirmed Elevated Blood Tests in Range 
(Number of Confirmed Elevated / 521 x 100) 
10-14 μg/dL 188 36.08 
15-19 μg/dL 122 23.42 
20-24 μg/dL 156 29.94 
25-44 μg/dL 47 9.02 
45-69 μg/dL 8 1.54 
>70 μg/dL 0 0.00 
 
 
ADULT LEAD POISONING 
Lead exposure occurs when lead dust or fumes are inhaled, or when lead is ingested via contaminated hands, 
food, water, cigarettes, or clothing. Lead entering the respiratory and digestive systems is released to the 
blood and distributed throughout the body. The toxic nature of lead is well-documented. Lead affects all 
organs and functions of the body to varying degrees. The frequency and severity of symptoms among 
exposed individuals depends upon the level of exposure. Once it is in the body, lead can be stored in organs 
and bones where it can cause serious and permanent damage to the kidneys, brain, heart, and reproductive 
system. Lead can damage the body even when someone is exposed to small amounts over a long period of 
time. Lead in bones may be released into the blood, re-exposing organs long after the original exposure.  
 
Most adults who do not work with lead as part of their job or during hobby activities have a low risk of 
exposure and are rarely tested. Persons who work with lead must be periodically tested through their 
worksite (when there is known high risk of exposure). Others should request testing from their personal 
medical provider (when there is a sporadic or low risk of exposure not known to meet the Occupational 
Safety and Health Administration (OSHA) requirement for testing) to monitor their actual level of exposure. 
Those with hobbies such as target shooting, hunting, casting or reloading ammunition, or involvement in art 
projects or other activities that utilize lead should be tested at least yearly. Testing can alert adults to the 
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need for preventive measures to protect their health and reduce the risk of spreading lead to their families. 
 
In 2014, the IDPH lead poisoning prevention program transitioned to a web-based data system to collect all 
blood lead test reports for Iowa residents from laboratories and medical providers reportable to IDPH under 
Iowa Administrative Code 641, Chapter 1. The 2014 data should be considered provisional (subject to 
change) and may not be complete at this time due to this transition. 
 
For 2014, blood lead tests of 10 micrograms per deciliter (µg/dL) or higher were defined as an elevated  
blood lead level (EBL) for an adult 16 years or older (age as of the date of collection) with residency in Iowa. 
Blood lead level (BLL) test results for 2,493 Iowa adults were reported to IDPH for calendar year 2014 (data 
as of May 2015) (Table 8). Based on the highest BLL in 2014 for each of these adults, there was a  
total of 759 Iowans (30.4 percent of those tested) who had blood lead levels of 10 µg/dL or higher: 611  
adults with levels 10-24 µg/dL, 139 adults with levels 25-39 µg/dL, and nine adults with levels 40 µg/dL or 
higher. The remaining Iowa adults tested (1,729, 69 percent) had results less than 10 µg/dL, with an  
average BLL less than 3 µg/dL.  
 
Descriptive analysis of the 2014 adult lead test data by gender, county, and source of exposure is not  
available at this time. Iowa’s high risk industries have remained consistent in the past, with about 90  
percent of the EBL adults working in manufacturing plants that use lead or metal products that contain lead. 
These workers are the most likely to be tested for lead exposure because of regulatory oversight or  
concerns about the risk of exposure in a fixed worksite environment. The second highest industry group is 
construction at about 3 percent of the adult EBLs. The construction industry includes industrial, commercial, 
and residential construction, painting, maintenance, and renovation projects. It is known that many  
workers in construction are not routinely tested for lead exposure. Other work-related cases in Iowa  
include exposures from electronic and scrap metal recycling, materials wholesalers and retailers,  
automotive or radiator repair, leaded glass workers and installers, transportation maintenance shops,  
and a variety of other work types. There are undoubtedly additional workers – especially those working for 
smaller companies or those who are self-employed – that have lead exposure but were never tested during 
2014. About 3 percent of adult EBLs in Iowa are due to non-work-related exposures. 
 
Table 8: Adult Blood Lead Level (BLL) Test Results - Iowa, 2011-2014 
2014 Data is 
Provisional 
Number of Iowa Adults       Tested by Highest BLL for Year 
Percent of all Iowa Adults 
Tested by BLL Range by Year 
IA ABLES DATA 2014 
2014 numbers 
vs. 2013 
Prior 3-yr 
Ave 
2013 2012 2011 2014 2013 2012 2011 
BLL 0-9 µg/dL 1729 -658 2276 2317 2187 2323 69.4% 72.8% 72.8% 73.6% 
BLL 10-24 µg/dL 611 -43 623 654 622 592 24.5% 20.6% 20.7% 18.8% 
BLL 25-39 µg/dL 139 -44 187 183 174 203 5.6% 5.8% 5.8% 6.5% 
BLL 40 µg/dL or 
higher 
9 -10 26 19 22 37 0.4% 0.6% 0.7% 1.1% 
All BLL 10+ 
(Total EBLS) 
759 -97 835 856 818 832 30.4% 27.2% 27.2% 26.4% 
Total Individuals 
Tested by Year 
2493 -680 3111 3173 3005 3155  
Adults:  Persons 16 years of age or older as of date of blood test. 
Iowa Adult Data:  Test results for adults with an Iowa residential address as of date of blood test.  Blood lead test reports received without address 
data or with a residential address outside of Iowa are not included in this report.   
Report reflects data as of May 4, 2015.   
TRAUMATIC WORK-RELATED FATALITIES SURVEILLANCE 
The IDPH Occupational Health and Safety Surveillance Program (OHSSP) includes the Iowa Fatality 
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Assessment and Control Evaluation (FACE) project, with work subcontracted to the University of Iowa College 
of Public Health, through funding provided by the National Institute of Occupational Safety and Health 
(NIOSH). The Iowa Office of the State Medical Examiner assists with this surveillance. 
 
Iowa FACE identified 83 work‐related fatalities for 2014 (provisional data) (Figure 30). The victims included 
80 males and three females aged 16 to 89 years, with a median age of 54. The workers were predominantly 
Caucasians, with fewer than 5 percent of the workers identified as Black, Hispanic, or another race or 
ethnicity.  
 
Figure 30. FACE work-related deaths - Iowa, 2001-2014   
 
 
Industry sectors with the highest numbers of traumatic worker deaths were 
agriculture/forestry/fishing/hunting (AFFH) with 22 fatalities (27 percent) and construction with 22 
fatalities (27 percent) (Table 9).  
 
Three types of incidents accounted for 70 of all work-related traumatic fatalities (84 percent), regardless 
of industry: transportation events, fall, slip and trip events, and contact with objects and equipment 
events.  
 
Transportation incidents accounted for 28 of all fatalities (34 percent), including 17 roadway fatalities 
and 11 off-roadway fatalities. AFFH sector deaths included 11 incidents involving transportation as a 
cause, with seven incidents involving off-road work and four involving on-road vehicles. Six of the deaths 
involved tractors and two deaths involved ATVs or four-wheeled utility vehicles being used for work. 
Construction sector deaths included six transportation fatalities, with four involving on-road incidents, 
and two off-road incidents.  
 
Falls, slips, and trips accounted for 22 of all fatalities (27 percent), with half of the deaths occurring in 
the construction sector. Incidents involving contact with objects and equipment followed with 20 (24 
percent) fatalities, 11 in AFFH (55 percent) and four in construction (20 percent). 
 
For fatalities to be included as a FACE “case,” the incident causing the work‐related death has to occur in 
Iowa (resident or non‐resident), and be traumatic in nature. Deaths that occur while commuting to or 
from work do not qualify. Deaths involving home or yard maintenance by the occupant or farm activities 
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not related to production farming are also excluded. Deaths from natural causes, chronic disease, or 
cancer are not included. Iowa workers killed while working out of state are not included. 
 
Some potential cases may not be identified due to lack of surveillance data, especially for individuals 
killed in motor vehicle crashes when it is unknown that the person was traveling as part of their job 
duties (other than commuting). Some cases are not identified until months after the incident. Case 
definition may also vary between agencies involved in worker surveillance. For these reasons, total case 
numbers may differ between those reported by other programs, such as the US Bureau of Labor 
Statistics (BLS), Census of Fatal Occupational Injuries (CFOI), or the Iowa Worker Memorial Day 
observance. 
 
Table 9. Traumatic work-related fatalities by industry sector of employer - Iowa, 2014 
NAICS Industry 
Code Group 
Industry Title 
2014 IA 
FACE* 
Percent 
Total* 
11 Agriculture, Forestry, Fishing and Hunting 22 27% 
21 Mining 1 1% 
22 Utilities 0  
23 Construction 22 27% 
31-33 Manufacturing 5 6% 
42 Wholesale Trade 5 6% 
44-45 Retail Trade 3 4% 
48-49 Transportation and Warehousing 4 5% 
51 Information 1 1% 
52 Finance and Insurance 2 2% 
53 Real Estate Rental and Leasing 3 4% 
54 Professional, Scientific, and Technical Services 0  
55 Management of Companies and Enterprises 0  
56 Administrative and Support and Waste Management 
and Remediation Services 
3 4% 
61 Educational Services 0  
62 Health Care and Social Assistance 1 1% 
71 Arts, Entertainment, and Recreation 0  
72 Accommodation and Food Services 3 4% 
81 Other Services (except Public Administration) 3 4% 
92 Public Administration 3 4% 
9999 Unknown/not able to classify* 2 2% 
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 2014 Iowa summary of reported outbreak investigations 
 
Table 10. Norovirus/Suspect Norovirus Outbreaks - Iowa, 2014 
Type 
Nature of 
Episode 
Event/Place County Month 
Number Affected / 
Number Exposed 
(if known) 
Agent Involved, Number 
of Positive Tests 
(if known) 
1. Norovirus Vomiting, 
Diarrhea 
Restaurant Multi-county February 8/8 Norovirus 
2. Norovirus Vomiting, 
Diarrhea 
Private Residence Story March 23/35 Norovirus - 3 
3. Norovirus Vomiting, 
Diarrhea 
Restaurant Polk/Webster/Dallas March 5/10 Norovirus - 2 
4. Norovirus Vomiting, 
Diarrhea 
Restaurant Polk/Webster/Dallas March 3/3 Suspect Norovirus 
5. Norovirus Vomiting, 
Diarrhea 
Workplace Polk/Webster/Dallas April 148/700 Norovirus GI - 3 
6. Norovirus Vomiting, 
Diarrhea 
Restaurant Polk May 5/35 Norovirus GII - 1 
7. Norovirus Vomiting, 
Diarrhea 
Restaurant Shelby/Crawford/Dallas October 13/17 Norovirus GII - 2 
8. Norovirus Vomiting, 
Diarrhea 
Restaurant Johnson December 8/9 Norovirus - 5 
9. Norovirus Vomiting, 
Diarrhea, 
Cramping 
Long-Term Care Polk January 44/100 Norovirus - 3 
10. Norovirus Vomiting, 
Diarrhea 
Long-Term Care Poweshiek January 16 Norovirus GI & G2 - 2 
11. Norovirus Vomiting, 
Diarrhea 
Assisted Living Polk January 12 Norovirus GII 
12. Norovirus Vomiting, 
Nausea, 
Diarrhea 
Long-Term Care Jasper January 26 Norovirus GII - 1 
13. Norovirus Vomiting, 
Diarrhea 
Assisted Living Cass January 11 Suspect Norovirus 
14. Norovirus Vomiting, 
Diarrhea 
Assisted Living Black Hawk February 48 Norovirus GII - 3 
15. Norovirus Vomiting, 
Diarrhea 
Workplace Story February 32 Norovirus GI - 4 
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Type 
Nature of 
Episode 
Event/Place County Month 
Number Affected / 
Number Exposed 
(if known) 
Agent Involved - Number 
of Positive Tests 
(if known) 
16. Norovirus Vomiting, 
Diarrhea 
Hospital Buena Vista February/March 19/45 Norovirus - 2 
17. Norovirus Vomiting, 
Diarrhea 
Long-Term Care Scott February/March 39 Norovirus GII - 2 
18. Norovirus Vomiting, 
Diarrhea 
Private Residence Cherokee March 11 Norovirus - 2 
19. Norovirus Vomiting, 
Diarrhea 
Long-Term Care Muscatine March 34/100 Norovirus - 2 
20. Norovirus Vomiting, 
Diarrhea 
Long-Term Care Warren March 45/92 Norovirus - 2 
21. Norovirus Diarrhea Workplace Linn March 5 Norovirus GI - 1 
22. Norovirus Vomiting, 
Diarrhea 
Elementary School Sioux March 59/428 Norovirus GII - 1 
23. Norovirus Vomiting, 
Nausea, 
Diarrhea 
Elementary School Henry May 46/302 Norovirus GI - 1 
24. Norovirus Vomiting, 
Diarrhea, Fever 
Long-Term Care Story April/May 23 Norovirus GII - 1 
25. Norovirus Vomiting, 
Diarrhea 
Wedding Dubuque May 35/250 Norovirus - 3 
26. Norovirus Diarrhea, 
Vomiting, 
Cramping 
Hospital Johnson May 13 Suspect Norovirus 
27. Norovirus Vomiting, 
Diarrhea 
Elementary School Linn October/November 12/48 Norovirus GII - 3 
28. Norovirus Vomiting, 
Diarrhea 
Long-Term Care Clinton November 16/43 + 1staff Norovirus GII - 2 
29. Norovirus Vomiting, 
Nausea, Fever, 
Headache 
Elementary School Scott November 70/642 Suspect Norovirus 
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Table 11. Foodborne Outbreaks - Iowa, 2014 
Type Nature 
of 
Episode 
Event/Place Location of 
Food 
Preparation 
Location of 
Food 
Consumption 
County Month Number Affected / 
Number Exposed  
(if known) 
Vehicle of 
Transmission 
Agent Involved - Number 
of Positive Tests  
(if known) 
1. Foodborne Vomiting, 
Diarrhea 
Restaurant Restaurant Restaurant Linn April/May 7/7 Unknown Unknown 
2. Foodborne Diarrhea Private Event Licensed 
Caterer 
Private Event Dubuque August 45/70 Unknown Clostridium perfringens - 4 
3. Foodborne Diarrhea Private 
Residence 
Private 
Residence 
Private Residence Linn September 5/15 Chicken Campylobacter jejuni - 2 
4. Foodborne Vomiting, 
Diarrhea 
Unknown Unknown Workplace Polk December unk/300 Unknown Unknown 
5. Foodborne Vomiting, 
Diarrhea 
Restaurant Restaurant Restaurant Johnson December 6 Unknown Salmonella enteritidis 
JEGX01.0005 - 5 
 
Table 12. Non-Norovirus, Non-Foodborne or Unknown Cause Outbreaks - Iowa, 2014 
Type Nature of 
Episode 
Event/Place County Month Number Affected / 
Number Exposed  
(if known) 
Vehicle of 
Transmission 
Agent Involved - Number 
of Positive Tests  
(if known) 
1. Foodborne Vomiting, 
Diarrhea 
Restaurant Linn January 3 Unknown Bacillus – 1; Shiga toxin - 1 
2. Person-to-Person Pruritus, Rash, 
Pustules, Crusts 
Hospital Clinton January - 
February 
42 Person-to-Person Crusted Scabies 
3. Person-to-Person Fever, Cough, 
Pneumonia 
Long-term Care Story April - May 62 Person-to-Person Human Metapneumovirus 
4. Person-to-Person Pruritus, 
Erythema 
Hospital Pottawattamie April-June 70 Person-to-Person Suspect Scabies 
5. Person-to-Person Pruritus, 
Erythema 
Long-term Care Henry May 4/100 Person-to-Person Crusted Scabies 
6. Environmental Diarrhea Long-term Care Howard April - May 4 Environmental Clostridium difficile 
7. Person-to-Person Respiratory Long-term Care Poweshiek November 16/43 + 1 staff Person-to-Person Influenza 
8. Person-to-Person Respiratory Long-term Care Shelby November 6 Person-to-Person Influenza 
9. Person-to-Person Respiratory Long-term Care Page November 3 Person-to-Person Influenza 
10. Person-to-Person Respiratory Long-term Care Carroll December 10/43 Person-to-Person Influenza 
11. Person-to-Person Respiratory Long-term Care Woodbury November 3 Person-to-Person Influenza 
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Type Nature of 
Episode 
Event/Place County Month Number Affected / 
Number Exposed  
(if known) 
Vehicle of 
Transmission 
Agent Involved - Number 
of Positive Tests  
(if known) 
12. Person-to-Person Dermatologic Long-term Care Clinton December ? Person-to-Person Scabies 
13. Person-to-Person Respiratory Long-term Care Cass December 4 Person-to-Person Influenza 
14. Person-to-Person Respiratory Long-term Care Mills December 16/50 Person-to-Person Influenza 
15. Person-to-Person Respiratory Long-term Care Jasper November -
December 
11/25 Person-to-Person Negative for viral/bacterial 
pathogens 
16. Person-to-Person Respiratory Long-term Care Marshall December 33/580 Person-to-Person Influenza 
17. Person-to-Person Respiratory Group Home Palo Alto December 2/14 Person-to-Person Influenza 
18. Person-to-Person Respiratory Assisted 
Living/Long-
term Care 
Webster December 5/316 Person-to-Person Influenza 
19. Person-to-Person Respiratory Long-term Care Harrison December 10/22 Person-to-Person Influenza 
20. Person-to-Person Respiratory Long-term Care Emmet December 35/82 Person-to-Person Influenza 
21. Person-to-Person Respiratory Long-term Care Sioux December 8/60 Person-to-Person Influenza 
22. Person-to-Person Respiratory Long-term Care Story December 3/180 Person-to-Person Influenza 
23. Person-to-Person Respiratory Long-term Care Hamilton December 12 Person-to-Person Influenza 
24. Person-to-Person Respiratory Long-term Care Polk December 7 Person-to-Person Influenza 
25. Person-to-Person Respiratory Long-term Care Emmet December 8/50 Person-to-Person Influenza 
26. Person-to-Person Respiratory Long-term Care Dubuque December 6/75 Person-to-Person Influenza 
27. Person-to-Person Respiratory Long-term Care Audubon December 6 Person-to-Person Influenza 
28. Person-to-Person Respiratory Long-term Care Washington December 10/100 Person-to-Person Influenza 
29. Person-to-Person Cough Community-
wide 
Winneshiek December 2014 
- February 2015 
24 Person-to-Person Pertussis 
30. Person-to-Person Respiratory Long-term Care O'Brien December 3 Person-to-Person Influenza 
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Type Nature of 
Episode 
Event/Place County Month Number Affected / 
Number Exposed  
(if known) 
Vehicle of 
Transmission 
Agent Involved - Number 
of Positive Tests  
(if known) 
31. Person-to-Person Respiratory Long-term Care Chickasaw December 8 Person-to-Person Influenza 
32. Person-to-Person Respiratory Long-term Care Dubuque December 14/58 Person-to-Person Influenza 
33. Person-to-Person Respiratory Long-term Care Dubuque December 9/204 Person-to-Person Influenza 
34. Person-to-Person Respiratory Long-term Care Hancock December 2014 
- January 2015 
4/22 Person-to-Person Influenza 
35. Person-to-Person Respiratory Long-term Care Boone December 2014 
- January 2015 
5/110 Person-to-Person Influenza 
36. Person-to-Person Respiratory Long-term Care Muscatine December 2014 
- January 2015 
5/70 Person-to-Person Influenza 
37. Person-to-Person Respiratory Long-term Care Carroll December 2014 
- January 2015 
9/79 Person-to-Person Influenza 
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Table 13. Reportable disease cases and rates per 100,000 population by age group - Iowa, 2014 
 
                   0 to 4                     5 to 19                    20 to 29                      30 to 39                  40 to 64                    >64                   Unk                  Total 
Disease Cases Rate Cases Rate Cases Rate Cases Rate Cases Rate Cases Rate Cases Cases Rate 
AIDS (diagnoses) 0 0.0 4 0.6 7 1.7 10 2.7 40 4.0 3 0.6 0 60 1.9 
Botulism 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Campylobacteriosis 66 32.7 95 15.4 89 21.6 91 25.1 169 16.9 61 13.5 0 571 18.7 
Chlamydia 6 3.0 3185 515.0 7036 1711.1 1286 355.4 294 29.4 0 0 0 11807 387.6 
  Cryptosporidiosis 40 19.8 58 9.4 32 7.8 44 12.2 54 5.4 36 7.9 0 264 8.7 
Dengue fever 0 0 1 0.2 2 0.5 0 0 1 0.1 0 0 0 4 0.1 
E. coli/shiga-toxin producing 49 24.2 60 9.7 42 10.2 25 6.9 33 3.3 15 3.3 0 224 7.4 
Ehrlichiosis/anaplasmosis 0 0 1 0.2 3 0.7 1 0.3 9 0.9 3 0.7 0 17 0.6 
Giardiasis 35 17.3 41 6.6 30 7.3 30 8.3 57 5.7 12 2.6 0 205 6.7 
Gonorrhea 1 0.5 351 56.8 892 216.9 290 80.1 103 10.3 4 0.9 0 1641 53.9 
Hemolytic uremic syndrome 3 1.5 2 0.3 0 0 0 0 0 0 1 0.2 0 6 0.2 
Hepatitis A 0 0 0 0 6 1.5 1 0.3 5 0.5 0 0 0 12 0.4 
Hepatitis B, acute 0 0 0 0 1 0.2 1 0.3 7 0.7 0 0 0 9 0.3 
Hepatitis B, chronic 1 0.5 13 2.1 82 19.9 77 21.3 97 9.7 13 2.9 0 283 9.3 
HIV (diagnoses) 0 0.0 7 1.1 28 6.7 20 5.3 42 4.2 2 0.4 0 99 3.2 
Legionellosis 0 0 0 0 2 0.5 3 0.8 16 1.6 12 2.6 0 33 1.1 
Listeriosis 1 0.5 0 0 0 0 0 0 2 0.2 4 0.9 0 7 0.2 
Lyme disease 9 4.5 51 8.2 17 4.1 14 3.9 70 7.0 33 7.3 0 194 6.4 
Malaria 3 1.5 3 0.5 4 1.0 3 0.8 4 0.4 0 0 0 17 0.6 
Meningococcal Inv. Disease 1 0.5 0 0 0 0 0 0 1 0.1 0 0 0 2 0.1 
Mumps 2 1.0 3 0.5 1 0.2 2 0.6 1 0.1 1 0.2 0 10 0.3 
Pertussis (whooping cough) 54 26.7 122 19.7 10 2.4 15 4.1 19 1.9 2 0.4 0 222 7.3 
Q fever 0 0 0 0 0 0 0 0 5 0.5 2 0.4 0 7 0.2 
Rocky Mountain spotted fever 0 0 0 0 2 0.5 2 0.6 6 0.6 0 0 0 10 0.3 
  Salmonellosis 79 39.1 80 12.9 57 13.9 69 19.1 174 17.4 68 15.0 0 527 17.3 
  Shigellosis 64 31.7 67 10.8 15 3.6 30 8.3 23 2.3 9 2.0 0 208 6.8 
Syphilis 0 0 11 1.8 80 19.5 53 14.6 87 8.7 8 1.8 0 239 7.8 
Tuberculosis 4 2.0 1 0.2 7 1.7 15 4.1 18 1.8 9 2.0 0 54 1.8 
Typhoid fever 0 0 0 0 0 0 0 0 1 0.1 0 0 0 1 0.0 
West Nile virus   1 0.5 1 0.2 3 0.2 0 0 8 0.8 2 0.4 0 15 0.5 
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Table 14. Reportable Disease cases and rates per 100,000 population by sex - Iowa, 2014 
 
 
                                                                                   Female                     Male                   Unk                  Total 
Disease Cases Rate Cases Rate Cases Cases Rate 
AIDS (diagnosis) 9 0.6 51 3.3 0 60 1.9 
Botulism 0 0.0 0 0.0 0 0 0.0 
Campylobacteriosis 248 16.1 323 21.4 0 571 18.7 
Chlamydia 8388 545.4 3419 226.7 0 11807 387.6 
Cryptosporidiosis 117 7.6 147 9.7 0 264 8.7 
Dengue fever 2 0.1 2 0.1 0 4 0.1 
E. coli and other shiga-toxin 
producing  127 8.3 97 6.4 0 224 7.4 
Ehrlichiosis/anaplasmosis  8 0.5 9 0.6 0 17 0.6 
Giardiasis 84 5.5 121 8.0 0 205 6.7 
Gonorrhea 862 56.0 779 51.6 0 1641 53.9 
Hemolytic uremic syndrome 5 0.3 1 0.1 0 6 0.2 
Hepatitis A 6 0.4 6 0.4 0 12 0.4 
Hepatitis B, acute 5 0.3 4 0.3 0 9 0.3 
Hepatitis B, chronic 121 7.9 162 10.7 0 283 9.3 
HIV (diagnoses) 20 1.3 79 5.2 0 99 3.2 
Legionellosis 13 0.8 20 1.3 0 33 1.1 
Listeriosis 4 0.3 3 0.2 0 7 0.2 
Lyme disease 73 4.7 121 8.0 0 194 6.4 
Malaria 8 0.5 9 0.6 0 17 0.6 
Meningococcal invasive disease 0 0 2 0.1 0 2 0.1 
Mumps 4 0.3 6 0.4 0 10 0.3 
Pertussis (whooping cough) 110 7.2 112 7.4 1 222 7.3 
Q fever 1 0.1 6 0.4 0 7 0.2 
Rocky Mountain spotted fever 1 0.1 9 0.6 0 10 0.3 
Salmonellosis 269 17.5 258 17.1 0 527 17.3 
Shigellosis 120 7.8 88 5.8 1 208 6.8 
Syphilis 43 2.8 196 13.0 0 239 7.8 
Tuberculosis 26 1.7 28 1.9 0 54 1.8 
Typhoid fever 0 0 1 0.1 0 1 0.0 
West Nile virus 7 0.5 8 0.5 0 15 0.5 
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Table 15. Reportable diseases by year - Iowa, 1994-2014 
Notifiable Disease 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 
AIDS (diagnosis) 110 104 97 75 60 77 81 80 74 76 70 78 79 68 66 91 73 73 71 82 60 
Anthrax 
                     
Botulism 
     
1 
    
1 
 
1 1 1 
      
Brucellosis 1 2 4 4 1 6 
 
2 1 
  
1 2 
 
2 2 
 
1 
 
2 
 
Campylobacteriosis 280 274 339 425 455 467 499 467 427 458 559 537 449 524 591 552 751 747 534 610 571 
Chlamydia 5412 5088 4165 4906 5173 5511 5989 5716 6241 6462 6958 7390 8399 8643 9372 9406 10542 10928 11139 11006 11807 
Cholera 1 
    
1 
             
1 
 
Cryptosporidiosis 71 21 75 71 66 56 77 82 49 122 90 122 230 610 284 232 397 364 328 1505 264 
Cyclosporiasis 
  
3 1 3 
  
1 
       
1 
 
1 
 
148 
 
Dengue Fever 
           
1 1 6 5 2 2 5 2 3 4 
Diphtheria 
                     
Ehrlichiosis / 
Anaplasmosis         
1 1 
 
4 7 7 7 8 2 8 6 8 17 
Encephalitis 
(arboviral, except 
WNV) 
1 13 19 3 3 3 4 3 3 
 
2 
 
1 1 
       
E. coli 54 64 123 114 93 114 180 81 122 103 124 108 161 185 208 163 173 189 181 171 224 
Hemolytic uremic 
syndrome*                  
13 10 6 6 
Giardiasis 339 391 410 358 429 377 420 345 315 277 301 280 302 301 326 291 284 270 251 275 205 
Gonorrhea 1645 1723 1144 1309 1615 1365 1394 1424 1496 1544 1249 1606 1981 1928 1700 1658 1804 1966 1982 1473 1641 
Haemophilus 
influenzae Type B 
6 3 4 6 5 2 
    
1 
 
2 1 2 1 1 3 
 
1 4 
Hansen's disease 
(Leprosy)     
1 
 
2 1 
   
1 1 
 
1 
 
1 
  
1 
 
Hantavirus  
   
2 1 2 
   
1 
    
1 
  
1 1 
  
Hepatitis A 64 106 346 490 400 161 67 41 72 40 50 22 13 48 109 38 11 8 7 17 12 
Hepatitis B 
 acute /chronic ** 
27/X 46/X 74/X 44/X 54/X 44/X 38/X 24/X 20/X 27/X 17/X 32/X 
21/ 
35 
26/ 
269 
24/ 
226 
37/ 
293 
15/ 
183 
15/ 
182 
13/ 
227 
11/ 
276 
9/ 
283 
Hepatitis B 
(perinatal)             
1 
 
1 
 
1 
    
Hepatitis C** 25 1 43 
     
1 1 
     
262 156 48 297 3 
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* includes cases starting 2011   **includes cases starting 2006  *** Hep C cases are not all entered due to limited staffing 
Notifiable Disease 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 
HIV (diagnosis) 
  
102 109 97 83 91 95 104 88 105 112 108 124 101 126 1114 119 117 122 99 
Legionellosis 34 21 11 12 11 17 15 8 13 12 8 8 13 12 21 24 16 11 13 11 33 
Listeriosis 
  
1 
 
2 6 2 3 5 
 
3 7 6 8 1 4 3 5 3 2 7 
Lyme disease 17 16 19 8 27 24 34 36 42 58 56 91 97 124 109 108 87 100 165 247 194 
Malaria 5 3 3 10 8 11 2 9 4 6 5 9 2 3 12 10 14 22 6 12 17 
Measles (Rubeola) 7 
 
1 
       
3 
    
1 
 
1 
   
Meningococcal 
invasive disease 
25 31 56 47 46 42 37 32 29 28 17 19 20 15 19 16 10 14 2 1 2 
Mumps 16 11 3 10 11 8 8 1 1 2 2 6 1.963 27 24 15 38 8 6 3 10 
Pertussis 23 11 32 207 78 111 67 167 230 182 1066 1106 342 150 257 235 705 232 1736 308 222 
Plague 
                     
Poliomyelitis 
                     
Psittacosis 
       
3 
   
1 
         
Rabies, animal 90 141 237 160 153 159 81 83 74 105 100 108 57 31 29 35 27 25 31 12 15 
Rabies, human 
         
1 
           
Rocky Mountain 
Spotted Fever 
1 
 
1 2 2 1 2 5 7 3 2 7 5 17 8 5 5 7 8 8 10 
Rubella  
(German Measles)      
30 
 
1 
             
Salmonellosis 404 433 335 296 375 260 373 339 509 413 435 410 475 477 425 408 530 448 622 575 527 
Shigellosis 338 351 151 90 69 74 569 367 122 93 64 103 134 109 214 53 57 18 91 342 208 
Syphilis 235 171 91 65 25 31 55 45 56 43 36 29 68 64 75 65 68 70 138 226 239 
Tetanus 1 
  
1 1 
 
1 
 
1 
  
1 
    
1 
  
1 
 
Toxic Shock 
Syndrome 
8 5 4 3 4 4 4 1 3 5 5 5 
  
1 2 1 1 1 1 
 
Trichinosis 1 6 
     
3 
   
1 
         
Tuberculosis 66 67 70 74 55 58 37 42 31 40 47 55 36 
 
46 42 48 40 46 47 54 
Tularemia 
               
1 
 
3 1 4 
 
Typhoid fever 
  
1 1 
 
1 
   
2 
   
1 6 
 
3 4 3 1 1 
West Nile virus 
        
52 147 23 37 37 30 5 5 9 9 31 44 15 
Yellow Fever 
               
2 
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Table 16. Salmonella serotypes reported - Iowa, 2014 
Subtype Serotype Cases 
 
Serotype Cases 
Salmonella Abony 1 Salmonella Mbandaka 4 
Salmonella Agbeni 2 Salmonella Monschaui 1 
Salmonella Agona 6 Salmonella Montevideo 10 
Salmonella Altona 2 Salmonella Muenchen 11 
Salmonella Anatum 2 Salmonella Napoli 1 
Salmonella Baildon 1 Salmonella Newport 33 
Salmonella Bareilly 4 Salmonella Oranienburg 9 
Salmonella Berta 5 Salmonella Oslo 1 
Salmonella Bovismorbificans 2 Salmonella Othmarschen 2 
Salmonella Braenderup 9 Salmonella Paratyphi B 1 
Salmonella Brandenburg 1 Salmonella Poona 2 
Salmonella Chiredzi 1 Salmonella Reading 6 
Salmonella Corvallis 1 Salmonella Roodepoort 1 
Salmonella Cotham 4 Salmonella Saintpaul 14 
Salmonella Dublin 2 Salmonella Sandiego 2 
Salmonella Enteritidis 93 Salmonella Schwarzengrund 1 
Salmonella Hadar 2 Salmonella Stanley 2 
Salmonella Hartford 3 Salmonella Tennessee 1 
Salmonella Heidelberg 10 Salmonella Thompson 12 
Salmonella Indiana 1 Salmonella Typhimurium 92 
Salmonella Infantis 21 Salmonella Urbana 1 
Salmonella Java 1 Salmonella Telelkebir 1 
Salmonella Javiana 8 Salmonella Species 13 
Salmonella Kentucky 1 Salmonella Subspecies I 71 
Salmonella Kiambu 2 Salmonella Subspecies IIIb 2 
Salmonella Kottbus 1 Salmonella Subspecies IV 1 
Salmonella Kuntair 1 
 
Unknown 46 
Salmonella Litchfield 2 Total 
 
530 
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Table 17. Shigella serogroups reported - Iowa, 2005-2014 
Shigella Serogroup 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 
Boydii 1 1 0 1 1 2 1 0 0 0 
Dysenteriae   1 0 0 0 0 0 0 2 0 
Flexneri 7 15 9 11 7 6 4 5 3 6 
Group B 3   2 0 0 0 0 0 0 0 
Group C     2 0 0 0 0 0 0 0 
Group D     1 1 0 0 0 10 0 0 
Sonnei 58 110 97 136 45 49 10 73 184 149 
Unknown 7 7 0 0 0 0 3 3 153 53 
Total 78 134 109 214 53 57 18 91 342 208 
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Table 18. Adult blood testing summary by county - Iowa, 2014 
COUNTY # tested # BLL result > 10 µg/dL COUNTY # tested # BLL result > 10 µg/dL COUNTY # tested # BLL result > 10 µg/dL 
Adair  1 0 Floyd  3 0 Monona 2 0 
Adams 4 0 Franklin 3 0 Monroe 9 6 
Allamakee 7 2 Fremont 5 4 Montgomery 17 5 
Appanoose 39 32 Greene 4 0 Muscatine 37 1 
Audubon 7 6 Grundy 6 2 O’Brien 1 0 
Benton 10 1 Guthrie 5 0 Osceola 1 0 
Black Hawk  67 19 Hamilton 22 0 Page 5 1 
Boone  13 2 Hancock 1 0 Palo Alto 1 0 
Bremer  13 0 Hardin 10 0 Plymouth 9 0 
Buchanan  222 172 Harrison 2 0 Pocahontas 2 0 
Buena Vista 2 0 Henry 7 0 Polk 219 4 
Butler 2 0 Howard 3 0 Pottawattamie 23 1 
Calhoun 5 0 Humboldt 9 0 Poweshiek 15 0 
Carroll 11 0 Ida 1 0 Ringgold 5 2 
Cass  30 19 Iowa 5 0 Sac 5 0 
Cedar 11 0 Jackson 52 36 Scott  216 7 
Cerro Gordo 22 0 Jasper 13 2 Shelby 2 2 
Cherokee 2 0 Jefferson 42 11 Sioux 6 1 
Chickasaw  1 0 Johnson 46 0 Story 37 0 
Clarke 3 2 Jones 27 5 Tama 16 0 
Clay 9 3 Keokuk 14 2 Taylor 3 0 
Clayton 213 184 Kossuth 3 1 Union 3 0 
Clinton 72 21 Lee 29 1 Van Buren 6 1 
Crawford 2 0 Linn 187 72 Wapello 58 12 
Dallas 21 1 Louisa 9 0 Warren 27 5 
Davis 4 1 Lucas 37 24 Washington 11 0 
Decatur 8 4 Lyon 2 2 Wayne 136 115 
Delaware 1238 1025 Madison 5 1 Webster 25 0 
Des Moines 12 0 Mahaska 61 11 Winnebago 4 0 
Dickinson 8 0 Marion 12 5 Winneshiek 5 0 
Dubuque 369 226 Marshall 20 7 Woodbury 41 4 
Emmet 3 1 Mills 6 2 Worth 1 0 
Fayette  98 68 Mitchell 3 0 Wright 3 0 
Based on highest test result in 2013 per adult (16 yo at time of test) residing in Iowa.1An elevated blood lead level 
(EBL) is considered a venous result greater than or equal to 10 micrograms per deciliter (µg/dL). Total (incl. suppressed data) 
 
4134 
 
2143 
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Table 19. Common reportable diseases by county - Iowa, 2014 
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ADAIR 1 0 0 7 1 0 0 0 2 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 
ADAMS 0 0 0 12 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 
ALLAMAKEE 0 0 8 33 2 1 4 0 2 0 0 0 1 0 0 4 0 1 0 0 0 3 0 0 1 0 
APPANOOSE 0 1 1 41 0 0 0 1 4 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
AUDUBON 0 0 0 13 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 
BENTON 0 1 15 66 7 4 0 2 4 0 1 0 2 2 0 0 0 0 1 0 1 3 0 1 0 0 
BLACK HAWK 3 6 17 816 1 3 0 5 198 0 0 0 20 3 0 2 0 1 5 0 0 21 8 7 4 0 
BOONE 0 0 4 65 4 0 0 2 4 0 0 1 0 1 1 0 0 0 0 0 0 2 0 3 1 0 
BREMER 1 0 7 51 0 2 0 1 3 0 0 0 1 0 0 0 0 0 0 0 0 5 0 1 0 0 
BUCHANAN 2 1 9 51 0 5 0 2 8 0 0 0 0 0 0 1 0 0 0 0 0 4 1 1 2 1 
BUENA VISTA 0 0 11 72 1 1 0 1 4 0 0 0 5 0 0 0 0 0 1 0 0 2 0 2 0 0 
BUTLER 0 0 8 24 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 
CALHOUN 1 0 1 18 1 3 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 
CARROLL 0 0 3 44 4 2 0 0 7 0 0 0 0 0 0 0 0 0 0 0 0 6 0 1 0 0 
CASS 0 1 6 36 2 0 0 1 1 0 0 0 1 0 0 0 0 0 1 0 0 9 0 1 0 0 
CEDAR 2 1 5 32 2 2 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 
CERRO GORDO 0 0 3 85 0 1 0 1 6 0 0 1 2 0 0 1 0 1 2 0 0 2 3 1 0 0 
CHEROKEE 0 0 1 23 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 
CHICKASAW 0 0 3 25 0 1 0 1 1 0 0 0 0 0 0 0 0 0 3 0 0 2 0 0 0 0 
CLARKE 0 0 0 31 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 
CLAY 0 0 4 53 1 2 0 1 0 0 0 0 1 0 0 0 0 0 1 0 0 3 0 0 0 1 
CLAYTON 4 0 3 31 10 1 0 0 2 0 0 0 0 0 0 6 0 0 0 0 0 3 0 0 0 0 
CLINTON 0 0 3 176 3 4 0 3 47 0 0 0 3 1 0 6 0 0 2 0 0 4 0 2 0 0 
CRAWFORD 0 0 11 78 0 1 0 0 3 0 0 0 1 0 0 0 0 0 3 0 0 3 0 0 1 2 
DALLAS 2 4 15 187 2 3 1 4 19 0 0 0 8 0 0 2 0 0 2 0 0 11 3 2 2 0 
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DAVIS 0 0 0 12 0 1 0 1 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 
DECATUR 0 0 2 36 0 0 0 0 1 0 0 0 0 0 0 0 0 0 15 0 0 1 0 0 0 0 
DELAWARE 0 0 9 42 11 6 0 3 2 0 0 0 0 0 0 0 0 0 1 0 0 4 15 0 0 0 
DES MOINES 0 0 11 182 5 0 0 3 14 0 0 0 0 2 0 4 0 0 1 0 0 9 1 5 2 0 
DICKINSON 0 1 2 34 1 4 0 2 1 0 0 0 0 0 0 0 0 0 0 0 0 10 0 1 0 0 
DUBUQUE 0 0 32 395 22 17 0 10 84 0 0 0 4 1 0 17 0 0 9 0 0 8 43 5 0 0 
EMMET 1 1 1 28 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 
FAYETTE 0 0 3 40 2 2 0 1 2 0 1 0 0 0 0 1 0 0 4 0 0 2 0 1 0 0 
FLOYD 0 0 3 37 2 4 0 2 2 0 0 0 1 0 0 1 0 0 0 0 0 4 0 1 0 0 
FRANKLIN 0 2 0 34 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 
FREMONT 0 0 2 20 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 
GREENE 0 0 1 29 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 
GRUNDY 0 0 2 22 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 
GUTHRIE 0 0 2 22 1 1 0 0 3 0 0 0 1 0 0 0 0 0 1 0 0 3 0 0 0 0 
HAMILTON 1 0 2 27 0 0 0 0 0 0 0 0 0 0 0 1 0 0 2 0 0 4 0 3 1 0 
HANCOCK 0 0 0 18 1 0 0 0 2 0 0 0 1 0 0 0 0 0 0 0 0 3 0 2 0 0 
HARDIN 0 0 2 32 0 1 0 3 4 0 0 0 0 0 0 1 0 0 1 0 0 3 0 0 0 0 
HARRISON 1 1 2 48 1 1 0 0 4 0 0 0 0 0 0 0 0 0 5 0 0 1 2 0 0 0 
HENRY 0 0 1 45 0 0 0 1 6 0 0 0 1 0 0 1 0 0 1 0 0 4 0 1 0 0 
HOWARD 0 0 0 24 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 
HUMBOLDT 0 0 1 16 2 0 0 2 1 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 1 
IDA 0 0 0 16 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 
IOWA 0 0 4 30 1 2 0 0 1 0 1 0 0 0 0 2 0 0 1 0 0 6 0 1 1 0 
JACKSON 0 0 7 38 7 7 0 1 5 0 0 0 0 0 0 10 0 0 0 0 0 3 0 0 0 0 
JASPER 0 0 4 93 12 6 0 2 11 0 0 0 2 0 0 3 0 0 0 0 0 5 0 0 0 0 
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JEFFERSON 0 0 1 33 1 0 0 2 1 0 0 0 2 0 0 3 0 0 0 0 1 0 0 1 0 0 
JOHNSON 2 6 24 727 4 12 6 8 82 0 0 0 19 0 0 42 0 0 14 0 2 26 15 24 7 0 
JONES 0 0 10 41 3 3 0 1 4 0 0 0 1 0 0 0 0 0 0 0 0 3 0 0 0 0 
KEOKUK 0 0 3 19 2 1 0 0 2 0 1 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 
KOSSUTH 0 0 1 27 1 1 2 0 1 0 0 0 0 0 0 1 0 0 0 0 0 7 4 0 0 0 
LEE 0 0 2 114 1 0 0 2 9 0 0 0 0 0 0 2 0 1 0 0 1 7 0 2 0 0 
LINN 7 15 53 1065 24 11 1 14 108 0 0 1 18 1 1 19 0 1 7 0 0 36 4 21 5 0 
LOUISA 0 0 2 25 1 0 0 1 0 0 0 0 4 0 0 1 0 0 1 0 0 0 2 0 1 0 
LUCAS 0 0 2 22 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 0 0 1 0 0 0 0 
LYON 0 0 10 10 2 1 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 6 0 0 0 0 
MADISON 0 0 2 16 1 0 0 0 4 0 1 0 1 0 0 0 0 0 2 0 0 1 1 0 0 0 
MAHASKA 0 0 5 77 3 3 0 2 13 0 0 0 0 0 0 0 0 0 0 0 1 3 0 2 1 0 
MARION 0 1 4 83 7 4 0 0 8 0 1 0 2 0 0 9 0 0 0 0 0 5 1 1 0 0 
MARSHALL 1 0 9 146 0 2 0 0 14 0 0 0 5 0 0 0 0 0 1 0 0 7 0 1 0 0 
MILLS 0 0 1 34 2 0 0 1 5 0 0 0 1 1 0 0 0 0 5 0 0 6 0 1 0 0 
MITCHELL 0 0 4 22 4 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 0 1 0 0 
MONONA 0 0 5 26 1 1 0 2 2 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 1 
MONROE 0 0 0 14 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 
MONTGOMERY 0 0 0 19 0 0 0 0 3 0 0 0 0 1 0 0 0 0 3 0 0 3 0 0 0 0 
MUSCATINE 1 0 3 156 6 3 0 1 12 1 0 0 3 1 0 11 0 1 20 0 0 6 0 4 4 0 
O'BRIEN 0 0 9 26 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 1 0 1 0 
OSCEOLA 0 0 3 10 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 2 2 0 0 0 
PAGE 0 0 0 58 1 0 0 0 2 0 0 0 0 0 0 0 0 0 1 0 0 2 0 0 0 0 
PALO ALTO 0 0 1 13 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 
PLYMOUTH 0 0 5 54 7 1 0 3 3 0 0 0 0 0 0 0 0 0 1 0 0 6 0 2 0 1 
POCAHONTAS 0 0 2 8 0 2 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 1 0 2 0 0 
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POLK 16 29 54 2,302 23 16 1 66 392 0 1 4 98 6 1 18 1 0 25 0 1 76 6 69 9 1 
POTTAWATTAMIE 4 8 10 427 5 11 0 2 89 0 0 0 9 0 1 0 1 0 7 0 0 14 3 7 0 1 
POWESHIEK 0 0 3 56 0 0 0 0 2 1 0 0 0 0 0 2 0 0 0 0 0 6 0 1 0 0 
RINGGOLD 0 0 0 11 1 2 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
SAC 0 0 2 14 1 1 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 4 0 0 0 1 
SCOTT 7 9 20 918 4 16 0 9 115 3 2 2 19 8 0 13 0 2 26 0 0 14 6 39 3 0 
SHELBY 0 0 1 20 7 4 0 0 4 0 0 0 1 0 0 0 0 0 0 0 0 8 0 2 0 0 
SIOUX 0 1 10 46 3 2 0 9 4 0 0 0 1 0 0 0 0 0 0 0 0 16 1 0 0 2 
STORY 0 2 14 418 6 3 0 6 31 0 1 0 17 0 0 2 0 0 1 0 0 8 1 4 1 0 
TAMA 0 1 5 57 1 5 0 1 11 0 0 0 0 0 0 0 0 0 0 0 0 4 0 1 0 0 
TAYLOR 0 0 1 10 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
UNION 0 1 0 43 0 1 0 1 4 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 
VAN BUREN 0 0 2 16 1 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 1 1 0 0 1 0 
WAPELLO 0 0 7 230 9 0 1 3 25 0 0 0 7 1 0 0 0 1 2 0 0 1 1 0 3 0 
WARREN 0 1 1 112 7 2 0 2 3 0 0 0 3 1 0 0 0 0 1 0 0 8 0 1 1 0 
WASHINGTON 0 0 12 39 1 0 0 0 3 0 0 0 1 0 0 2 0 0 0 0 0 4 0 0 1 0 
WAYNE 0 0 0 6 0 0 0 1 0 0 0 0 0 0 0 0 0 0 9 0 1 0 0 0 0 0 
WEBSTER 0 0 3 185 3 1 0 2 45 0 1 0 3 1 1 0 0 0 0 0 0 4 2 1 0 0 
WINNEBAGO 0 0 2 19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 1 0 0 0 0 
WINNESHIEK 0 0 10 33 3 7 0 0 2 0 0 0 1 0 0 4 0 0 13 0 0 4 1 0 0 0 
WOODBURY 1 3 19 576 4 9 0 6 160 0 0 0 10 1 1 0 0 0 6 0 0 22 77 7 1 3 
WORTH 0 0 0 6 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 
WRIGHT 2 2 3 28 2 1 0 0 4 0 0 0 0 0 0 0 0 0 1 0 0 2 0 1 0 0 
Total 60 99 571 11807 264 224 17 205 1641 6 12 9 283 33 7 194 2 10 222 0 10 527 208 239 54 15 
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